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ABSTRACT 
The O-antigen is a component of the LPS, a surface molecule that covers the surface of bacteria 
including Salmonella. The O-antigen has an important role in infection as it is recognized by the 
host immune system. Salmonella is a Gram-negative foodborne bacterial pathogen causing 
inflammation in the gut and diarrhea or an invasive typhoidal disease. The O-antigen of 
Salmonella has been known to be modified by gtr genes, a group of three genes: gtrA, gtrB and 
gtrC found within an operon, which have been found to mediate the addition of a glucose 
molecule on to the repeating unit of the O-antigen. However, the family IV Gtr proteins’ 
function has not been identified but a study has shown that they may be needed for persistence 
within a host. This project studied the expression of these genes, using a beta-galactosidase 
assay and RT-qPCR, and looked at their ability to mediate modifications to the Salmonella O-
antigen using LPS extraction and analysis techniques. The results of this study show expression 
from transcriptional start sites within the operon suggesting that GtrC(IV) can be expressed 
independently of the remainder of the operon. The results also show that GtrAB(IV) can replace 
the function of other GtrAB proteins of known function indicating that they are able to bind and 
transfer a glucose to a GtrC protein. However, this study was not able to show that GtrC(IV) 
was targeting the O-antigen, it also found that there is no common sugar amongst the family IV 
core O-antigens. This suggests that either further unidentified modifications are needed to be 
made to the O-antigen or the O-antigen is not the target of GtrC(IV). 
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1. INTRODUCTION 
 
1.1 SALMONELLA  
 
Salmonella is a Gram-negative foodborne bacterial pathogen. The genus Salmonella, part of the 
Enterobacteriaceae family is made up of two species: Salmonella bongori and Salmonella 
enterica. S. enterica, the most well studied Salmonella species, contains six subspecies (Coburn 
et al., 2007). Within Subspecies are serovars, for example Typhimurium is a serovar of the 
subspecies S. enterica subsp. enterica and is referred to as S. Typhimurium. The enterica 
subspecies is the most well studied as it contains 99% of all serovars responsible for disease in 
warm blooded animals (Chan et al., 2003). The serovars in the enterica subspecies are grouped 
into serotypes determined by the structure of their lipopolysaccharide (LPS) and flagella. The 
serotype is determined by agglutination with specific sera to these two structures (Grimont and 
Weill, 2007).  
 
The specific symptoms of salmonellosis depend on host, their susceptibility and the infecting 
serovar. Typhoidal serovars cause an invasive, systemic disease, which is accompanied by an 
absence of an inflammatory mucosal response in the intestine (Dougan and Baker, 2014). In 
humans, typhoidal disease is caused by the S. enterica serovars Typi and Paratyphi A. Non-
typhoidal serovars are less invasive, causing inflammation in the gut and diarrhea and generally 
causing a less life threatening disease (Kolodziejek and Miller, 2015). However, in recent years 
some strains of non-typhoidal Salmonella (NTS) have been found to cause a more invasive 
disease similar to typhoidal serovars in immunocompromised patients in Sub Saharan Africa 
(Crump and Heyderman, 2015). In humans NTS is caused by multiple serovars of S. enterica 
including S. Typhimurium and S. Enteritidis (Bangtrakulnonth et al., 2004) However, in mice S. 
Typhimurium causes a typhoidal disease.  The main focus if this project was NTS serovars.  
 
Inflammation in the gut, caused by the invasion of epithelial cells by NTS, can be utilized to the 
advantage of the Salmonella pathogen. During inflammation and episodes of diarrhea the gut 
can become devoid of nutrients (Santos et al., 2009), affecting both the pathogen and 
commensal gut bacteria. To overcome this problem S. Typhimurium can use available 
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ethanolamine as a nutrient during anaerobic growth. This requires tetrathionate as an electron 
acceptor, which is a molecule produced by the inflamed gut (Thiennimitr et al., 2011). This 
metabolic pathway is not available to commensal gut bacteria allowing Salmonella a growth 
advantage, which aids colonization of the gut, persistence and transmission (Rivera-Chavez and 
Baeumler, 2015).  
 
Salmonella is an intracellular bacterium that can invade host cells such as epithelial cells and 
macrophages to avoid clearance by the immune system. To facilitate its invasion Salmonella 
utilizes a type three-secretion system (T3SS) needle to transport proteins across a membrane. S. 
Typhimurium has two T3SS contained within Salmonella pathogenicity island 1 (SPI-1) or 2 on 
the chromosome (Kolodziejek and Miller, 2015). The SPI-1 T3SS is used for invading cells and 
injects effector molecules into a host cell to stimulate its uptake by the cell. Effector molecules 
released through the T3SS are also important in activating the inflammatory response in the gut 
needed for colonization of NTS (LaRock et al., 2015).   
 
Once inside the host cell Salmonella is contained within a Salmonella containing vacuole 
(SCV), which matures into a unique niche for Salmonella to reside within the cell. Effector 
proteins injected by the SPI-1 T3SS can remain in the invaded cell and aid the formation of the 
SCV (Hernandez et al., 2004). The SPI-2 T3SS needle is assembled whilst in the SCV and is 
used by the bacteria to deliver effector proteins into the cytosol of the host cell to promote 
intracellular survival of the pathogen. As well as the bacteria in the SCV there is a select 
population of Salmonella that are free in the host cell cytosol. These pathogens quickly replicate 
to fill the host cell with bacteria, which are equipped and ready to invade new host cells 
(Knodler et al., 2010). Host cells, full with cytosolic Salmonella are shed into the gut lumen, 
where they undergo inflammatory cell death. This process releases the invasion primed 
Salmonella into the gut lumen, which facilitates further invasion of host cells from the gut and 
shedding of the bacteria from the gut so that the pathogen can complete its life cycle (Knodler et 
al., 2010).   
 
1.1.1 Components of the Gram-negative bacterial cell envelope 
 
As bacteria are single celled organisms they need to be able to withstand stress and changes in 
their environment. The Gram-negative bacterial cell wall has two phospholipid bilayers: an 
inner membrane and an outer membrane. Between the two membranes is the periplasmic region 
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containing many proteins and the peptidoglycan cell wall (Silhavy et al., 2010). The 
peptidoglycan layer is made up of repeating units of two sugars: N-acetyl glucosamine (NAG) 
and N-acetyl muramic acid (NAM). Multiple chains of NAG and NAM are linked by peptide 
cross bridges (Vollmer et al., 2008). The flagellum is an important surface component for 
motility and chemotaxis and can be recognized by the host immune system (Eom et al., 2013). 
Attached to the outer membrane are lipopolysaccharide (LPS) molecules, which are important 
for immune recognition of the pathogen and are responsible for eliciting an immune response to 
infection (Galanos et al., 1984). The LPS will be discussed in more detail below. 
 
NTS, along with many other bacteria, can form biofilms to aid their persistence within the 
environment and their host. Bacterial biofilms can be made up of various components, the 
components that are necessary for formation depends on the colonization site. For example, 
colanic acid and cellulose have been found to be needed for biofilm formation on chicken 
intestinal tissue and human epithelial type 2 cells but only cellulose is required for formation on 
a plastic surface (Ledeboer and Jones, 2005). The O-antigen capsule, among other types of 
capsules, can comprise part of the biofilm. Recently, the O-antigen capsule of S. Typhimurium 
has been shown to confer resistance to killing by human serum (Marshall and Gunn, 2015). The 
O-antigen capsule is very similar to the O-antigen of the LPS (discussed below) but is a much 
larger molecule with a higher molecular weight allowing it to form a capsule across the 
bacterial surface (Snyder et al., 2006).  
 
1.2 THE O-ANTIGEN OF LIPOPOLYSACCHARIDE (LPS)  
 
The outer membrane of Gram-negative bacteria is mostly covered by LPS, a lipid molecule that 
is anchored in to the membrane whilst binding sugar repeats that extend out from the outer cell 
surface. A bacterium’s LPS plays an important role in activating an inflammatory response. The 
innate immune system will recognize LPS molecules using pattern recognition receptors that 
will recognize and bind LPS, activating an immune response (Dixon and Darveau, 2005; 
Gyorfy et al., 2013). For NTS activation of an immune response is an important step during 
infection (Thiennimitr et al., 2011).  
 
The LPS is made up of three constitutive parts: the lipid A, the core oligosaccharide and the O-
antigen. Lipid A is the domain that anchors LPS into the outer membrane and contains the 
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hydrophobic, lipid component of the LPS. The structure of this lipid is highly conserved 
between Gram-negative bacteria and is almost constant within enterobacteria. As well as acting 
as an anchor, lipid A is the toxic part of the LPS, when released from the membrane the LPS 
can diffuse through the host environment via its hydrophilic O-antigen whilst the lipid A 
domain will activate a strong immune response. The second domain is the core oligosaccharide, 
which joins the O-antigen to the lipid A anchor. It is composed of a short chain of sugars, the 
outer region connects to the O-antigen and the inner region binds the lipid A anchor (Lerouge 
and Vanderleyden, 2002).  
 
The third component is the O-antigen repeating unit. This hydrophilic molecule is composed of 
a repeating unit of sugars forming a chain with as many as 40 repeats. The repeating unit has 
between 3-5 oligosaccharide subunits which are specific to each serovar of Salmonella 
(Lerouge and Vanderleyden, 2002). Variations in O-antigen sugar content can produce multiple 
antigenic types and give rise to specific immunological responses. The basic S. Typhimurium 
O-antigen repeating structure is galactose-rhamnose-mannose with an abequose side chain 
attached to mannose  and in serotype O5, for example, the abequose sugar is acetylated (Hauser 
et al., 2011) (figure 1).  
 
 
 
 
 
 
 
 
Figure 1: O-antigen structure of S. Typhimurium O4 and O5 serotypes 
Serotype O5 has a modification of an acetyl group attached to the abequose side chain shown 
in red. Sugar moieties have been abbreviated: mannose (Man), rhamnose (Rha), galactose 
(Gal), abequose (Abe) and OAc indicates the acetyl group.  The anomeric configuration of the 
sugar is given to the left and the carbon numbers involved in the bond are given underneath. 
Carbon 2 of abequose is bound by the acetyl group in serotype O5. Structural information 
taken from Micoli et al., 2014. 
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β
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1.2.1 The O-antigen role in infection 
 
The O-antigen, being the variable component of the LPS, can determine specific virulence 
factors. For example, some O-antigen structures and sugar components can promote adhesion of 
the bacterial cell to the epithelial cell wall. In Helicobacter pylori the Le(X) structure of the O-
antigen enables the bacteria to adhere to the human gastric epithelium which may promote 
colonization of the mucosal surface (Edwards et al., 2000). It has also been shown that specific 
sugars can slow the pathogens uptake by macrophages (Liang-Takasaki et al., 1982). As well as 
variation in composition, the length and number of repeating sugars in the O-antigen can 
provide defense against the lytic action of compliment by keeping it away from the bacterial 
cell surface and preventing it forming pores in the membrane (Grossman et al., 1987).  
 
1.2.2 Genes Involved in determining the structure and composition of the O-
antigen. 
 
The genes responsible for determining the sugars that make up the O-antigen are the rfb genes. 
This cluster of genes encodes biosynthesis enzymes, for the biosynthesis of the sugar 
precursors, and specific sugar transferases that will transfer the sugars onto a lipid carrier, 
undecaprenyl pyrophosphate (UndPP), ready to be flipped across the membrane (Jiang et al., 
1991; Kalynych et al., 2014). The wzx/wzy group of genes is involved in the next step of LPS 
formation. The Wzx protein flips the lipid carrier linked chain of sugars across the membrane 
into the periplasm and is transferred to the Wzy protein. This protein then adds the subunit of 
sugars to a growing chain that will make up the O-antigen. The length of the chain is regulated 
by the Wzz protein (Batchelor et al., 1991).The O-antigen chain of sugars is then ligated onto 
the lipid A and core oligosaccharide to from a complete LPS molecule (Islam and Lam, 2014). 
Variations in these genes can produce multiple O-antigen structures and affect the virulence of a 
pathogen.  
 
There are also genes outside of the rfb cluster that can modify the O-antigen. Such as the oafA 
gene in S. Typhimurium or the oacD gene in Shigella flexneri (Sun et al., 2014) that can add an 
acetyl group onto a specific sugar. For example in S. Typhimurium the OafA protein will add an 
acetyl group onto the abequose moiety of the O-antigen which will define this bacterium as an 
O5 serotype (Slauch et al., 1996).   
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Modifications of the O-antigen can affect how the pathogen is recognized by the immune 
system and may be important for O-antigen associated virulence factors. Shigella flexneri, 
causing shigellosis associated with diarrhea and fever, has been shown to have multiple 
modifications to its O-antigen repeating unit. For example, the rhamnose II of the core O-
antigen unit can be modified by the addition of a glucose at a 1-3 position. This results in the 
conversion of S. flexneri from serotype Y to serotype 5a. This modification is mediated by the 
gtr operon which encodes the serotype specific protein GtrV (Allison and Verma, 2000).  
 
Bacteriophage are known to carry genes that can positively affect the virulence of their bacterial 
hosts. For example, it has recently been shown that, as well as encoding the shiga toxin, shiga-
toxigenic bacteriophage can effect the expression of the bacterial host’s acid response genes 
improving its survival in the stomach (Veses-Garcia et al., 2015). But bacteriophage can also 
carry genes that prevent the co-infection of the bacterial host. The O-antigen is often used as a 
receptor for bacteriophage binding to the bacterial cell surface, therefore to avoid co-infection it 
is thought that some bacteriophage can mediate the modification of the O-antigen. For example, 
the P22 Salmonella bacteriophage carries a gtr operon that mediates the addition of a glucose 
molecule onto the galactose moiety of the S. Typhimurium O-antigen. O-antigen modification 
by these genes are thought to prevent co-infection with other P22 bacteriophage as the P22 tail-
spike protein cleaves the O-antigen to gain better access to the bacterial surface. This cleavage 
activity is prevented by the glycosylation of the galactose moiety of the O-antigen (Kintz et al., 
2015).  
 
1.3 THE GTR OPERON AND THE ENCODED PROTEINS 
 
Many Salmonella serovars contain glucosyltransferase (gtr) operons.  The gtr operons of known 
function encode proteins that can change the serotype of the strain by specifically modifying the 
O-antigen through addition of a glucose molecule (Davies et al., 2013). This project will focus 
on the gtr genes present in multiple serovars of S. enterica subsp. enterica. 
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1.3.1 Model of Gtr proteins function 
 
gtrB, the second gene in the gtr operon, is proposed to be a bactoprenol glucosyltransferase 
whose function is to transfer a glucose molecule from UDP-glucose onto a undecaprenyl-
pyrophosphate(UnDP) lipid carrier(Allison and Verma, 2000). The GtrA protein is proposed to 
be a flippase that flips UnDP-glucose across the inner membrane of the cell wall so that it can 
be accessed by GtrC in the periplasm (Allison and Verma, 2000; Nair et al., 2011). In the 
periplasm GtrC will transfer the glucose from the UnDP lipid carrier onto a specific point on the 
O-antigen. This is thought to occur during the synthesis of the O-antigen before it is attached 
onto the lipid A core (Allison and Verma, 2000). A diagram showing the model of the Gtr 
proteins activity can be found in figure 2. All known function Gtr proteins in both Salmonella 
and S. flexneri have been found to mediate the addition of a glucose molecule (Allison and 
Verma, 2000). However, it is possible that gtr families of unidentified function could be binding 
and transferring a sugar other than glucose.  
 
 
 
 
 
 
 
 
 
 
GtrC
GtrA GtrB
Wxy
Periplasm
Cytoplasm
UDP-Glucose
Lipid	
carrier
UnDP-
Glucose
Growing	
O-antigen
Figure 2: A model of gtrABC protein activity. 
The GtrB protein is a bactoprenol glucosyltransferase, which transfers a glucose 
molecule from UND-glucose onto a undecaprenyl-pyrophosphate(UnDP) lipid carrier. 
UnDP-Glucose is then bound by GtrA which flips it across the membrane into the 
periplasm so that it can be accessed by GtrC. GtrC is a glucosyl transferase that 
transfers the glucose onto the growing O-antigen chain, at a specific point, whilst it is 
being formed in the periplasm. (Adapted from Lerouge and Vanderleyden, 2002)    
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1.3.2 The gtr proteins are split into 10 families  
 
The P22 phage encoded Gtr proteins were used to identify other gtr-like genes across 57 
Salmonella strains including both S. enterica and S. bongori and four genomes of bacteriophage 
known to modify the O-antigen of Salmonella (Davies et al., 2013). This was done using a 
BLASTn analysis which found 59 other gtr-like genes, mainly within S. enterica subs. enterica. 
The 59 operons cluster in to 10 families based on the sequence of gtrC, as this is the proposed 
serotype specific gene. The gtrA and gtrB genes do not follow the same pattern of clustering as 
their gtrC counterparts. This was predicted to be due to recombination events between operons 
of different families as gtrA and gtrB sequences are well conserved across the families so 
function of the operon would not be disrupted by recombination (Davies et al., 2013). To date 
the functions and specific modifications mediated by the family I, II, III and VIII proteins have 
been elucidated. Also, Davies et al., has demonstrated that the family VI and V proteins mediate 
the addition of a molecule to the S. Infantis O-antigen repeating unit but details of the 
modification are not known. As the GtrC protein of each family is targeting a specific moiety of 
the basal O-antigen they are confined to serovars that produce an O-antigen containing their 
target. For example, all family I and III containing strains have a galactose moiety as part of 
their core O-antigen structure, the sugar target of both these families.  
 
More than one gtr family can be found in the same strain, for example in the S. Typhimurium 
serovar the family IV proteins usually share the genome with the family III genes. In S. Infantis 
family IV, family V and VI gtr genes have been found in the same genome (Davies et al., 
2013).  
 
1.3.3 Glycosylation by the Family I, III and VIII gtr operons 
 
Family I, III and VIII all mediate very similar modifications to the core Salmonella O-antigen. 
Family I includes the gtr operon encoded by the P22 bacteriophage, the most well studied gtr 
genes. These genes (previously known as the a1 gene) mediate the addition of glucose onto the 
galactose moiety of the basal unit via a 1-6 linkage (Mäkelä, 1973) (figure 3). Their function 
was first identified by Young and his group who showed that a1 mutants are unable to produce 
antigen 1. This is now referred to as an O:1 serotype, which is produced after conversion by 
GtrABC proteins encoded in the P22 genome (Byl and Kropinski, 2000; Fukazawa and 
Hartman, 1964).   
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The role of the family III Gtr proteins was shown in the S. Typhimurium serovar. The 
STM0557/0558/0559 genes, which are gtr genes CBA respectively, were also shown to transfer 
a glucose molecule onto a galactose moiety but via a 1-4 linkage as apposed to a 1-6 linkage 
(figure 3). It was also shown that these genes were needed for persistence within the murine 
intestine (Bogomolnaya et al., 2008). Although this result should be considered with the 
knowledge that this operon phase varies (Broadbent et al., 2010), which was not controlled for 
during their experiments. The phase variation of the surface proteins may have ensured 
persistence and not the specific modification. 
 
The family VIII gtr operon is encoded by the Salmonella bacteriophage epsilon 34. Proteins 
encoded in the epsilon 34 genome modify the O-antigen of S. Anatum by addition of a glucose 
at a 1-4 position to the beta-galactose moiety of the core O-antigen unit (Reeves et al., 2013) 
(Villafane et al., 2008). This is almost identical to the modification mediated by family III but is 
specifically targeting a beta-galactose moiety. Before conversion by epsilon 34, S. Anatum must 
first be converted by Salmonella bacteriophage epsilon 15.  Epsilon 15 blocks the activity of the 
host cell O-polysaccharide alpha polymerizing enzyme to replace it with its own O-
polysaccharide beta polymerizing enzyme, which produces an O-antigen core structure with a 
beta, rather than alpha, galactose moiety (Kropinski et al., 2007), which can be targeted by GtrC 
of epsilon 34.  
 
 
 
 
 
 
 
 
 
 
 
  19 
1.3.4  Acetylation by the Family II gtr operon 
 
Unlike the other gtr operons the family II Gtr protein is thought to transfer an acetyl group onto 
the O-antigen. It is proposed that GtrC(II), produced from the BTP1 prophage, mediates the 
addition of the acetyl group found at the C-3 and C-2 positions of the rhamnose moiety of the S. 
Typhiumurium str. D23580 O-antigen (Kintz et al., 2015; Micoli et al., 2014) (figure 3). 
Interestingly the family II GtrC does not require GtrAB to function and consequently, the gtr 
operons that have been studied have had either deleted or mutated gtrAB gene sequences (Kintz 
et al., 2015; Davies et al., 2013).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gal	Man	 Rha
α
1,4
β
1,2
α
1,4/6Abe
α
1,3
Glu
OAc2/3
α
1,3
Figure 3: Modifications to the O-antigen structure of S. Typhimurium 
mediated by Gtr proteins of family I, II, and III. 
Family I mediates the addition of a glucose at the 1, 6 position and family III at the 1, 
4 position on the galactose moiety. Family II mediates the addition of an acetyl group 
onto the rhamnose moiety at either carbon 2 or 3. Modifications are indicated in red. 
Sugar moieties have been abbreviated: mannose (Man), rhamnose (Rha), galactose 
(Gal), abequose (Abe) and OAc indicates the acetyl group.  The anomeric 
configuration of the sugar is given to the left and the carbon numbers involved in the 
bond are given underneath. Structural information taken from Micoli et al., 2014. 
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1.3.5 Expression of the gtr operon and phase variation  
 
Several gtr gene clusters, including the P22 gtrABC genes, have been shown to regulate their 
expression through phase variation via a Dam and OxyR dependent system. Two pairs of 
GATC sites, that can be methylated by Dam, were identified upstream of the gtrA 
transcriptional start site, which overlaps three OxyR binding sites. Differential methylation of 
each GATC pair determines whether the promoter is in an off or on state. When the downstream 
GATC pair in methylated OxyR is unable to bind at the downstream sites leaving it free for 
RNA polymerase to bind. However, when the upstream GATC pair is methylated the OxyR 
can’t bind and instead binds to the downstream GATC sites blocking RNA polymerase binding 
to the promoter preventing transcription (Broadbent et al., 2010). It is thought that the on or off 
state is heritable due to the methylated GATC sites but the method of switching is still 
unknown. The heterogeneous population, created by phase variation, may be an important 
virulence strategy of the bacteria, for example in evasion of the adaptive immune response 
(Woude and Bäumler, 2004).  
1.4 THE FAMILY IV GTR OPERON  
 
1.4.1 The family IV Gtr proteins importance in infection  
 
This project studied the family IV gtr genes. Very little is known about these genes and their 
proteins’ functions, but it has been hypothesized that they work to modify the O-antigen 
repeating unit based on their sequence similarity with Gtr families with known function.  As 
mentioned above, the O-antigen can have an important role during infection. Further studies 
into its structure and modifications have the potential to inform therapeutic methods of tackling 
Salmonella infection.  
 
More specifically the family IV proteins are important to study as they have recently been 
shown to be required for persistence within four different host animals (Chaudhuri et al., 2013). 
In this study each gene was separately mutated and used to infect chickens, pigs, cattle and 
mice. gtrA(IV) and gtrB(IV) mutants showed a significantly reduced persistence within all 
animals apart from the mouse. Whereas, the gtrC(IV) mutant showed significantly reduced 
persistence within all host animals including the mouse. Therefore, the family IV genes may be 
needed for virulence within a host. 
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1.4.2 Expression of the family IV gtr genes under infection relevant conditions  
 
A recent study has used RNA-seq to look at the transcriptional profile of S. Typhimurium under 
various infectious relevant growth conditions and generated heat maps for every gene (Kröger 
et al., 2013). The heat maps generated for the family IV gtr genes don’t show any points of very 
high expression. And the level of mRNA does vary from each gene, which could be due to 
mRNA degradation after transcription. However, there are a few conditions that show higher 
levels of transcription than others: under nitric oxide shock gtrA(IV) shows its highest level of 
transcription with gtrC(IV) also showing high levels of transcription. pH3 shock also induces 
some of the highest levels of transcription particularly in gtrC(IV). (Kröger et al., 2013).  
 
When Salmonella is infecting a host it will experience conditions of NO shock from the 
immune response mounted against it. Intracellular and extracellular Salmonella can trigger the 
expression of inducible nitric oxide synthase (iNOS) causing production of NO from immune 
cells like macrophages and dendritic cells (MacMicking et al., 1997; Kalupahana et al., 2005). 
This response has also been seen in human intestinal epithelial cells after bacterial invasion 
(Salzman et al., 1998). pH3 conditions are relevant to infection because this is the pH of the 
gastric system of humans (Goktepe et al., 2005) and other common hosts of S. Typhimurium 
like pigs (Crévieu-Gabriel et al., 1999; Wilkins et al., 2010) is around pH3.   
 
Experiments done alongside the RNA-seq transcriptome study (Kröger et al., 2013) looked 
globally for transcriptional start  sites within the S. Typhimurium genome.  Terminator 
exonuclease was used to enrich a sample of RNA for primary transcripts by selectively 
degrading 5’-monophosphorylated transcripts before RNAseq. This experiment found two 
possible transcriptional start sites (TSS) within the gtrB(IV) gene upstream of gtrC(IV) 
(personal correspondence with Disa Hammerlof – exact positions of the TSS’s were not 
available). This shows that gtrC(IV) could be being transcribed independently of gtrAB(IV). 
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1.4.3 The function of the family IV Gtr proteins  
 
Very little is known about the function of the family IV genes, but some hypotheses can be 
made based on the results of the studies mentioned above. As well as demonstrating the genes 
importance in infection, the Chaudhuri et al., (Chaudhuri et al., 2013) results suggest that 
GtrC(IV)’s function doesn’t always rely on the expression of GtrAB(IV) as the gtrC(IV) mutant 
was the only family IV gtr mutant attenuated in the mouse model. This difference may be a 
result of the conditions the pathogen is under; it will have encountered a different environment 
in the mouse as it was infected intravenously whereas the other three animals were infected 
orally. Also, S. Typhimurium causes a typhoid like infection in mice, unlike the other animals 
studied. It may be that at certain points during infection only GtrC is needed for virulence. The 
data showing possible TSS within gtrB(IV) also supports the theory that GtrC(IV)’s function 
may not always rely on GtrAB(IV). If gtrC(IV) is being transcribed independently it may be 
because it is need at different times during the infection process.  
 
Unlike most of the other families, family IV’s gtrA and gtrB genes cluster into the same groups 
as the family IV gtrC’s. This is probably because there has been no recombination of the family 
IV operon with other family operons, this may be because GtrC(IV) is unable to function with 
GtrAB(IV) from other families and can only function with GtrAB(IV). This could also mean 
that the role of GtrC differs from other family GtrC’s. These conclusions are in contrast to the 
conclusion that GtrC may work independently of GtrAB mentioned previously. It could be that 
GtrC can function by itself at certain points during infection and at others it relies on GtrAB.  
 
Another dissimilarity of the family IV gtr genes is that the operon’s expression does not phase 
vary in the same way as some other gtr operons. No GATC sites, necessary for phase variation 
through a OxyR and Dam dependent mechanism, were found up stream of gtrA(IV). Nor was 
phase variation seen when the operons regulatory region was in front of the lacZ gene. 
Therefore, they have a different mechanism of controlling gene expression compared to some 
other gtr families which have been shown to phase vary. This could mean that their role in 
virulence is different as well.   
 
Davies et al (Davies et al., 2013) demonstrated that the family I, III, V and VI Gtr proteins 
functioned to modify the O-antigen by extracting the LPS from strains (S. Typhimurium was 
used when expressing families I and III and S. Infantis for families V and VI) that were 
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constitutively expressing only one of these gtr families, all other O-antigen modifying genes 
had been removed. The LPS was analysed using gel electrophoresis, which produces a banding 
pattern showing varying lengths of O-antigen repeating units. When comparing this banding 
pattern to one belonging to a basal strain, which contains no known O-antigen modifying genes, 
there is a shift seen between the two banding patterns showing that a molecule has been added 
to the O-antigen repeating unit. However, when the family IV genes were analysed in this way, 
in an S. Typhimurium strain, no shift was seen between the banding pattern of a strain 
constitutively expressing the family IV genes and the banding pattern of a basal strain 
expressing no known O-antigen modifying genes.  
 
This could be due to multiple reasons. The GtrC substrate or target is not available, for example 
GtrC(IV) may target a modification of the S. Typhimurium O-antigen, possibly one provided by 
another Gtr family. The GtrC is not adding anything to the LPS but just changing the bonds 
between the sugars. The mRNA transcript of the constitutively expressed family IV operon is 
not being translated into protein under normal laboratory conditions. There is also the 
possibility that GtrC is not acting on the LPS and its target is something else.  
 
 
1.5 AIMS OF THE PROJECT 
 
The aim of the project was to gain an insight into the function of the family IV Gtr proteins, a 
range of techniques were used to do this. Modifications made to the O-antigen by other Gtr 
families was studied to test whether they provide a target for GtrC(IV) activity. GtrAB(IV) was 
studied to test whether their function is unique to GtrC(IV) or whether they could replace the 
function of GtrAB proteins from other families. The expression of the gtr(IV) genes was studied 
under infection relevant conditions to understand what role the proteins might have in infection. 
The independent expression of GtrC(IV) was also investigated as this suggests that GtrC(IV) 
may work independently of GtrAB(IV). A bioinformatics analysis was carried out to predict the 
function of the Gtr(IV) proteins and compare their amino acid (AA) sequence to Gtr proteins of 
known function.  
 
Collectively, these studies may give an insight into the function of the family IV Gtr proteins. 
The family IV proteins may be important for infection in certain hosts (Chaudhuri et al., 2013) 
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and as they are thought to be involved in surface modification, an understanding of their 
function and role in infection could inform development of therapeutic methods against 
salmonellosis. 
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2. MATERIAL AND METHODS 
 
2.1 DNA ANALYSIS 
 
2.1.1 Agarose gel electrophoresis 
1% agarose gel was prepared by melting 1% (W/V) agarose (Sigma-Aldrich) into TAE buffer 
(Life Technologies). The gel was left to cool slightly before pouring into a cast then adding 
ethidium bromide to a final concentration of 0.2 µg/ml. Once set the gel was placed into a gel 
tank filled with TAE buffer. DNA samples were loaded along with a GeneRuler DNA Ladder 
Mix (Thermo Scientific) and ran at 100V. Visualisation was done in G:BOX gel doc (Syngene). 
 
2.1.2 DNA quantification 
A NanoDrop 1000 (Thermo Scientific) was used to measure DNA concentration by measuring 
the light absorbance at an optical density (OD) 260. Readings at OD280 and OD230 were also 
taken to measure the contamination of the sample. A 1µl sample was loaded for measurement.  
 
2.1.3 Sequencing  
A SmartSeq kit from Eurofins Genomics Company was used to sequence lengths of up to 
1100bp of purified PCR products or extracted plasmid. Samples were prepared according to the 
manufacturers instructions. 
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2.2 BACTERIAL CULTURE AND GROWTH MEDIA  
 
2.2.1 Solid and liquid Lennox broth (LB) media  
LB powder (Fisher Scientific) was dissolved in ddH2O to a final concentration of 20g/L. when 
making solid media; powdered agar (Fisher Scientific) was added to a final concentration of 
17.5g/L. The solution was then autoclaved. Antibiotics were added to the required concentration 
(table 1) once the media had cooled to 55°C. Whilst solid media was still melted it was poured 
into plates and dried in a lamina flow hood. 
Table 1: Antibiotic concentrations 
 
 
2.2.2 Solid and liquid M9 minimal media  
 
M9 salts (Sigma) were dissolved in ddH2O and autoclaved. Once cooled to 55°C nutrients, 
listed in table 3, were added to the required concentration. If solid media was being prepared 
powdered agar was dissolved in ddH2O to a final concentration of 17.5g/L, autoclaved then 
cooled to 55°C. This was then added to M9 minimal media in a 1:1 ratio, mixed and poured into 
plates before drying in a lamina flow hood.  
 
2.2.3 InSPI2 (Inducing Salmonella Pathogenicity Island II) media 
 
See table 2 for components and concentrations. Once all components were dissolved the 
solution was adjusted to pH 5.8 and filter sterilized. The recipe for InSPI2 media was taken 
from Kröger et al., 2013. 
 
 
 
Antibiotic	 Final	cocentration
Ampicillin 100μg/ml	
Chloramphenicol	 34μg/ml	
Table	1:	Antibiotic	concentrations	
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2.2.4 Growth conditions 
 
Strains were cultured overnight in a 10 ml volume tube by inoculating 5 ml of LB with one 
colony (colonies were grown on an LB agar plate containing appropriate antibiotics) of bacteria 
in a 37°C incubator with shaking at 25 rpm unless otherwise specified. Appropriate antibiotics 
were added to the required concentration.  
 
2.3 POLYMERASE CHAIN REACTION (PCR) AND 
PURIFICATION 
 
High fidelity PCR was performed using either Q5® Hot Start High-Fidelity DNA Polymerase 
(NEB) or KOD Hot Start DNA Polymerase (Merck-Millipore). 
For diagnostic PCR GoTaq® G2 Flexi DNA polymerase (Promega) was used. Product specific 
protocols were followed for all. Colony, plasmid or purified PRC product were used as 
template. Primers were purchased in freeze-dried form from Sigma and resuspended in ultra 
pure H2O (milliQ by Millipore) to a concentration of 100µM. PCR products were purified using 
QIAquick PCR Purification Kit (QIAGEN). The protocol provided with the kit was followed.  
 
2.4 PLASMID EXTRACTION AND CONCENTRATION 
  
Strains containing the plasmid were cultured overnight in a 10 ml volume tube by inoculating 5 
ml of LB with one colony (colonies were grown on an LB agar plate containing appropriate 
antibiotics) of bacteria in a temperature specific incubator with shaking at 25rpm. Appropriate 
antibiotics were added to the required concentration. Plasmid was then extracted from the 
saturated culture using the QIAprep Spin Miniprep kit (QIAGEN). The protocol provided with 
the kit was followed.  
  
The concentration of the extracted plasmid was determined using the method described in 
section 2.1.2. If a higher concentration of plasmid was required a miVac DNA Concentrator 
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(Genevac) was pre-warmed to 50°C before spinning the plasmid for an appropriate amount of 
time to evaporate water from the sample.  
2.5 RESTRICTION ENZYME DIGESTS 
 
All restriction enzymes were from NEB and used according to the manufacturer’s instructions. 
Restriction digests were performed on either extracted plasmids or purified PCR products.  
 
2.6 LIGATION 
 
When ligating insert to vector a 3:1 molar ratio was used. T4 DNA ligase from NEB was used 
for all ligations and the protocol provided was followed.  
 
2.7 BACTERIAL TRANSFORMATION BY 
ELECTROPORATION 
 
Strains were grown to saturation in liquid media overnight (O/N) with appropriate antibiotics 
and at the required temperature with shaking. The next morning new liquid media was 
inoculated with a 1 in 100 dilution of O/N culture and grown to an OD600 of between 0.4-0.6. 
OD600 was measured using a Jenway 6505 spectrophotometer.   
 
Once the OD600 0.4-0.6 was reached between 5-50ml (depending on the efficiency of 
transformation needed) was centrifuged for 15 min at 5000xg at 4°C. Supernatant was removed 
then an equivalent volume of autoclaved ultra pure H2O was used to re-suspend the pellet 
before centrifuging again for 8 min under the same conditions. This step was repeated a further 
2-4 times. The final pellet was re-suspended in 100µl. 50µl of this solution was pipetted into a 
Gene Pulser/Micropulser Electroporation Cuvette with a 0.2 cm gap width (BioRad) along with 
1-4µl of plasmid/ligation solution. A BioRad MicroPulserTM was used to apply a current for 
electroporation and was operated according to the instructions provided with the machine, the 
EC2 setting was used for all transformations. 1ml of SOC media (table 4) was added 
immediately after electroporation.  
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The culture was then incubated for 1 hour at 37°C with shaking unless specified otherwise. 
100µl of culture was then spread on appropriately prepared plates. The remaining culture was 
centrifuged at 5000xg for 5 min. The supernatant was removed and the pellet was re-suspended 
in 100µl of LB before spreading. Plates were then incubated O/N at the required temperature. 
These methods were adapted from a protocol developed by Erica Kintz. 
 
2.8 GENOME INTEGRATION AND THE CRIM VECTOR 
 
lacZ gene constructs were integrated into the chromosome using the CRIM vector as described 
by Haldimann and Wanner, 2001. Briefly, after cloning of a desired region into the CRIM 
vector, in front of the lacZ gene between the Pst1 and Acc651 restriction sites, the plasmid was 
transformed by electroporation into a pir+ strain. This strain was then grown to saturation in LB 
liquid media containing chloramphenicol (34µg/ml) before extraction of the plasmid.  This was 
then electroporated into a S. Typhimurium LT2 strain containing a pINT-temperature sensitive 
(ts) plasmid, which can express the phage integrase protein for integration into the 
chromosomal attB phage insertion site. Before electroporation this strain was grown at 30°C 
with ampicillin (100µg/ml) to maintain the pINT-ts plasmid. Once the CRIM vector had been 
transformed into this strain the culture was immediately grown at 37°C when integration of the 
CRIM vector took place and then at 42°C at which the pINT-ts plasmid was lost. Any un-
integrated CRIM vectors were also lost as they were Pir dependent.  
 
2.9 LPS EXTRACTION 
 
2.9.1 Extraction and preparation of LPS 
 
If the strain was induced before LPS extraction an O/N culture grown in LB was diluted 1 in 
100 and grown to OD600 0.6 then induced with 1mM of IPTG then grown O/N before LPS was 
extracted. 1ml of O/N culture was centrifuged for 5 min at 8000xg and the supernatant 
discarded. The pellet was re-suspended in 100µl of LPS buffer A (table 5), vortexed and boiled 
for 5 min. 400µl of LPS buffer B (table 5) was added and vortexed before adding 2µl of RNase 
(Roche) and DNase (Sigma) and incubated at 37°C for 5 hours. 5µl of proteinase K (10 mg/ml) 
was then added, votexed and incubated at 50°C O/N.  
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25µl of each sample was mixed to a 1:1 ratio with loading buffer (table 12), vortexed, boiled for 
6 min then cooled to room temperature before loading into a TSDS-PAGE gel. These steps 
were modified from the methods used by Davies et al., 2013. 
 
2.9.2 Preparation and running of TSDS-PAGE gel.  
 
The separating gel (table 6) was pipetted between the glass casting plates leaving around a 5cm 
space above. A layer of water-saturated butanol was pipetted on top and the gel was left to 
polymerize. Once polymerized the water saturated butanol was washed off and the stacking gel 
(table 7) pipetted into the cast and the well comb was inserted. Once the stacking gel had 
polymerised the comb was removed and the gel, between the casting plates, was attached to the 
tank. Anode (0.2M tris, pH8.9) and cathode buffers (table 8) were poured into the bottom and 
top chambers respectively. Once loaded, the gel was ran at 50V until the die front had passed 
through the stacking gel when it was turned up to 100V and ran overnight then stopped once the 
die front had reached the end of the gel. This protocol was modified from the methods used by 
Lesse et al., 1990.   
 
2.9.3 Silver staining of TSDS-PAGE gel.  
 
All steps were performed at room temperature with slow agitation. The gel was first fixed in 
fixative solution (table 9) for 3-5 days. It was then placed in oxidizer (table 10) for 10 minutes 
then washed three times with milli-Q water for 15 minutes. The gel was stained with silver stain 
solution (6mM silver nitrate) for 30 minutes in a foil-covered container. The gel was rinsed with 
milli-Q water before transferring into the developer solution (table 11) and developing for 10-45 
min or until sufficiently developed.  The silver reaction was then stopped with 1% acetic acid. 
This protocol was modified from the methods used by Kittelberger and Hilbink, 1993.  
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2.10  NITRIC OXIDE SHOCK (NO) SHOCK  
 
Growth conditions followed those used by Kröger et al., 2013. O/N cultures grown in M9 
minimal media (see section 2.2.2) were inoculated 1 in 100 in 50 ml of InSPI2 media (see 
section 2.2.3 and table 2). The culture was grown at 37°C with shaking until an OD600 of 
around 0.3 was reached, during the beta-galactosidase assay a sample was taken at this point. 
The culture was then split into pre-warmed glassware and one half was given 250µM of 
spermine NONOate. The cultures were grown for a further 20 min before sampling. During the 
beta-galactosidase assay a sample was also taken 60 min after spermine NONOate addition.   
 
2.11  PH3 SHOCK 
 
Growth conditions followed those used by Kröger et al., 2013. O/N cultures were inoculated 1 
in 100 in 50 ml of LB media. The culture was grown at 37°C with shaking until on OD600 of 
around 0.3 was reached. The culture was then split into two pre warmed falcon tubes and 
centrifuged for 7 min at 5000xg. The supernatant was removed and one tube of pelleted culture 
was re-suspended in LB at pH3, acidified by addition of HCl, and the other with LB at pH7. 
This was then poured into pre-warmed glassware and grown at 37°C with shaking for 10 min/5, 
10 and 15 min before sampling. 
 
2.12  BETA-GALACTOSIDASE ASSAY 
 
A protocol developed by Miller, 1972 was followed: samples of culture were taken and their 
OD600 was recorded. They were chilled on ice for 10-20 min before dilution in Z buffer to a 
final volume of 1 ml at the relevant ratio. 50µl and 100µl of 0.1% SDS and chloroform 
respectively were added and the mixture was vortexed for 10 sec. These samples were then pre-
incubated at 28°C for around 5 min. 200µl of ortho-nitrophenyl-β-galactoside (ONPG) solution 
(4mg/ml ONPG dissolved in a phosphate buffer solution at pH7 made by combining 0.1M of 
NaH2PO4 and Na2HPO4 at a 1 to 1.56 ration) was added and vortexed for 10 sec before returning 
to incubation at 28°C. The time of ONPG addition was recorded. Once the solution had turned a 
pale yellow colour the reaction was stopped with 0.5ml of 1M Na2CO3 and the time was 
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recorded. The solution was centrifuged for 15 min at 8000xg. The supernatant was removed and 
its OD420 was recorded.  
 
A formula was used to calculate the expression of beta-galactosidase in Miller units: Beta-
galactosidase units = (1000 x OD420) / (T x V x OD600), where ‘T’ is time of the reaction in 
minutes and ‘V’ is volume of the culture used in ml.  
 
2.13  RNA EXTRACTION  
 
The RNeasy mini Kit (QIAGEN) and Bacteriaprotect reagent (QIAGEN) were used for RNA 
extraction. The protocol provided with the Bacteria protect reagent was followed. 2.5ml of 
culture was sampled for RNA extraction.  
 
RNA sample was then checked for genomic DNA contamination. A 2µl aliquot of extracted 
RNA (or 2µl of genomic DNA used as a positive control) was mixed with 125µl of a sterile 
buffer (60mM Tris-HCl, 1mM EDTA, at pH6.8). 2 µl of Dnase-free Rnase (Roche) was added. 
The solution was incubated O/N at 37°C. A diagnostic PCR was performed using primers to be 
used in the RT-qPCR reaction and GoTaq® G2 Flexi DNA polymerase (Promega). 
 
2.14  CDNA SYNTHESIS 
 
SuperScript™ II Reverse Transcriptase (Invitrogen) was used and the accompanying protocol 
was followed.  
 
2.15  RT-QPCR 
 
An Applied Biosystems Fast qPCR machine was used. Each reaction contained 20µl total 
volume containing: 10µl fast SYBR green master mix (Applied Biosystems), 7µl nuclease free 
  33 
water, 0.5µl of each primer (250nM), 2µl cDNA or nuclease free water as the negative control. 
The thermal cycling conditions used were: initial denaturation for 20 sec at 95°C followed by 
40 cycles of denaturation for 3 sec at 95°C then a combined annealing and extension step at 
60°C for 30 sec. After cycling was complete a melt curve was performed: initial denaturation 
was performed at 95°C for 5 sec. The temperature was then held at 60°C for 1 min before 
gradually increasing at 0.3°C increments from 60°C to 95°C then held at 95°C for 15 sec. The 
level of fluorescence is recorded across the gradual heating period to detect the temperature at 
which the double stranded product denatures. The change in fluoresces over time is plotted 
against the temperature to produce a melt curve.  
 
2.16  BIOINFORMATICS ANALYSIS 
 
Functional domain prediction of GtrABC family IV proteins was done using the InterPro: 
protein sequence analysis & classification tool (Mitchell et al., 2014). 
All AA and nucleotide sequence aliments were generated using Cobalt Constraint-based 
Multiple Protein Alignment Tool (Papadopoulos and Agarwala, 2007a) and Align Sequences 
Nucleotide BLAST tool (Altschul et al., 1990) respectively. Parameters of alignments are given 
in figure legends. All transmembrane domain prediction was done using TMHMM Server v. 2.0 
available at http://www.cbs.dtu.dk/services/TMHMM/ unless specified otherwise.   
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3. BIOINFORMATICS ANALYSIS OF THE FAMILY 
IV GTR GENES AND PROTEINS 
 
 
Very little is known about the family IV operon and the three encoded proteins. The operon has 
previously been found in the genomes of multiple strains from different eight serovars (Davies 
et al., 2013). The family IV proteins are predicted to modify the O-antigen due to sequence 
similarity with other known O-antigen modifying genes but this function was not able to be 
demonstrated in previous studies (Davies et al., 2013). The family IV gtr operon has not 
undergone any recombination events with other family’s operons (mentioned in section 1.4.3) 
unlike gtr operons of other gtr families (Davies et al., 2013). This could suggest that the 
function of these proteins is slightly different, and therefore recombination of the operon with 
gtr genes from other families would result in a non-functional operon. This section compares 
the family IV proteins with proteins from other families. It also identifed newly sequenced 
strains containing the gtr(IV) genes and analyse their O-antigen structures. 
 
3.1 THE SPREAD OF GTR GENES ACROSS THE 
SALMONELLA SEROVARS  
 
In 2013 Davies et al identified 57 gtr operons in the genomes of S. enterica, S. bongori and 
Salmonella bacteriophage and assigned them to ten different families based on their gtrC 
sequence. Since then more Salmonella strains have been sequenced. BLASTn analysis was 
done using a gtrC nucleotide sequence from families one to seven. This identified many other 
gtr operons in newly sequenced S. enterica strains. A list of the O-antigen groups of each 
serovar was collected from the: ‘Antigenic formulae of the Salmonella serovars’ compiled by 
the WHO Collaborating Centre for Reference and Research on Salmonella (Grimont and Weill, 
2007). The O-antigen group is determined through agglutination with specific antisera and 
refers to the core O-antigen structure (European Food Safety Authority, 2010) (Grimont and 
Weill, 2007). This showed the range of O-antigen structures of each family’s serovars.  
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Table 2: List of serovars containing each family of gtr genes 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2 lists the serovars that each family were found in and the number of strains in each 
serovar that contain the genes and also the O-antigen group of each serovar. The cells 
highlighted in green show newly identified serovars that contain gtr genes. But in previously 
identified serovars there were also newly sequenced strains that were found to contain gtr 
genes. The Typhimurium serovar in particular had many newly sequenced strains that contained 
gtr operons. One strain of Typhimurium was found to have gtr genes of family V and VI gtr 
families not previously found in Typhimurium. Another notable observation about the family V 
and VI gtr families is that they were always found together in a strain. This could indicate that 
they are carried by the same bacteriophage, which is supported by the observation that they both 
map to the same, phage associated SPI-16, genomic region in S. Typhimurium.  
 
The BLASTn analysis showed that, to date, the family IV gtr genes are present in the largest 
number of serovars. Family IV was also one of the most widely spread families in terms of the 
number of strains it has been found in. But Family III and family II are found within the largest 
number of strains. Although, this is mainly because family II and III are found in the Enteritidis 
serovar, which make up the bulk of the strains in these families.  
 
Family	I		 Family	II	 Family	III	 Family	IV		
Serovar	 No.	of	strains		 O-an7gen	group	 Serovar	 No.	of	strains		
O-an7gen	
group	 Serovar	 No.	of	strains		
O-an7gen	
group	 Serovar	 No.	of	strains		
O-an7gen	
group	
Heidelberg	 5	 O:4	 Gallinarum	 3	 O:9	 Dublin	 2	 O:9	 Tennessee		 1	 O:7	
Dublin	 2	 O:9	 Pullorum		 3	 O:9	 Pullorum		 3	 O:9	 Thompson	 4	 O:7	
Typhimurium		 7	 O:4	 Dublin	 2	 O:9	 Gallinarum	 3	 O:9	 Paratyphi	C	 1	 O:7	
Abony		 1	 O:4	 Paratyphi	A	 5	 O:2	 Typhimurium		 21	 O:4	 Infan7s		 1	 O:7	
Pullorum		 1	 O:9	 Typhi	 12	 O:9	 Agona		 3	 O:4	 Choleraesuis		 3	 O:7	
Paratyphi	A	 5	 O:2	 Typhimurium		 3	 O:4	 Heidelberg	 5	 O:4	 Typhimurium		 22	 O:4	
YU39*	 1	 	 	Enteri7dis	 ≥100	 O:9	 Paratyphi	B	 1	 O:4	 Agona		 3	 O:4	
	 	 Panama	 1	 O:9	 Heidelberg	 5	 O:4	
	 	 	Javiana	 1	 O:9	 YU39*	 1	 -	
	 	 	Enteri7dis	 ≥100	 O:9	 Bovismorbiﬁcans		 1	 O:8	
	 	 Typhi	 6	 O:9	 Hadar	 1	 O:8	
	 	 Paratyphi	A	 5	 O:2	 Newport		 12	 O:8	
	 	 Abony		 1	 O:4	 Anatum		 4	 O:3,10	
	 	 YU39*	 1	 -	 Sen[enberg	 1	 O:1,3,19	
	 	 	 Ouakam	 1	 O:9,46	
	 	 	 Cubana	 1	 O:13	
Total	strains	 22	 	 Total	strains	 ≥128	 	 Total	strains	 ≥153	 	 Total	strains	 62	 	
Family	V	 Family	VI	 Family	VII	
Serovar	 No.	of	strains		 O-an7gen	group	 Serovar	 No.	of	strains		
O-an7gen	
group	 Serovar	 No.	of	strains		
O-an7gen	
group	
Choleraesuis		 3	 O:7	 Choleraesuis		 3	 O:7	 Newport		 12	 O:8	
Paratyphi	C	 1	 O:7	 Paratyphi	C	 1	 O:7	 Bovismorbiﬁcans		 1	 O:8	
Typhimurium		 1	 O:4	 Typhimurium		 1	 O:4	 Hadar	 1	 O:8	
Thompson	 4	 O:7	 Thompson	 4	 O:7	
Infan7s		 1	 O:7	 Infan7s		 1	 O:7	
Bareilly		 1	 O:7	 Bareilly		 1	 O:7	
Tennessee		 1	 O:7	 Tennessee		 1	 O:7	
Montevideo	 3	 O:7	 Montevideo	 3	 O:7	
	 	
	 	
	 	
	 	
	 	
	 	
	 	
	 	
Total	strains	 15	 	 Total	strains	 15	 	 Total	strains	 14	 	
Green	cells	indicate	newly	iden7ﬁed	serovars.	
*YU39	indicates	the	strain	not	the	serovar	and	is	refereeing	to	Salmonella	enterica	subsp.	enterica	strain	YU39		
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As well as being wide spread across serovars, Table 2 showed that the family IV gtr genes came 
from 7 different O-antigen groups. This was a large amount compared to the other gtr families 
that had between one and three different O-antigen groups. Davies et al., observed that the gtr 
families were contained within limited O-antigen groups that share the same core O-antigen 
structure. This is most likely because the GtrC protein targets a specific moiety of the O-antigen 
structure and can only function in certain O-antigen groups. Although, the family IV genes 
seem to be maintained within strains of a range of O-antigen groups.  
 
3.2 THE O-ANTIGEN STRUCTURE OF THE SEROVARS 
CONTAINING THE FAMILY IV GTR GENES 
 
The GtrC is thought to add a sugar molecule onto a specific residue of the O-antigen repeating 
unit. To predict which residue is modified by the family IV proteins the basic structure of the 
repeating units of all serovars containing the family IV gtr genes were compiled into a table and 
compared to identify conserved sugars. The basic O-antigen structure of each serovar was 
identified from their O-antigen group (Liu et al., 2014a). As the family IV gtr genes come from 
a range of different O-antigen groups, shown above, this could indicate that the O-antigen 
structures are also diverse.  
 
Information on other gtr families in that serovar was included in the table as they can provide 
modifications to the basic O-antigen structure. For example, family I and III are known to add a 
glucose molecule onto a galactose at different positions (Young et al., 1964) (Bogomolnaya et 
al., 2008). The family V and VI are known to modify the O-antigen in some way (Davies et al., 
2013) but the specific modifications are not known. 
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Family	IV	
Serovar No.	of	strains	 Other	gtrs in	strain O-antigen	group*	 O-antigen	structure
Tennessee	 1
V/VI
O:7	(C1)
Thompson 4
Paratyphi C 1
Infantis	 1
Choleraesuis 3 V/V/VI
Typhimurium	 18
III
O:4	(B)
Agona 3
Heidelberg 5
Typhimurium	
1	(Str.	L-3553)
II/III1	(Var.	5-Str.	CFSAN001921)
1	(Str.	D23580)
1	(Str.	FORC_015) V/VI
YU39** 1 I/III - -
Bovismorbificans	 1
VII O:8	(C2-C3)Hadar 1
Newport	 12
Anatum 4 - O:3,10	(E1)
Senftenberg 1 - O:1,3,19	(E4)
Ouakam 1 - O:9,46	(D2)
Cubana 1 - O:13	(G)
*The	new	O-group	classification	 scheme	is	given	first	and	the	old scheme	is	in	brackets.
**YU39	indicates	the	strain	not	 the	serovar and	is	refereeing	to	Salmonella	enterica subsp.	enterica strain	 YU39
Man		 Man		 GlcNac		Man		 Man		
α	
1,2	
α	
1,2	
β	
1,2	
β	
1,3	
β	
1,2	
Gal		Man		 Rha		
α	
1,3	
α	
1,4	
β	
1,2	
Gal		Rha		 Man		
α	
1,2	
α	
1,2	
Man		
α	
1,3	
α	
1,4	
Abe		α	
1,3	
Gal		Man		 Rha		
α	
1,3	
β	
1,4	
α	
1,6	
Gal		Man		 Rha		
α	
1,3	
β	
1,4	
α	
1,6	
Glc		α	
1,6	
Gal		Man		 Rha		
α	
1,3	
β	
1,4	
α	
1,6	
Tyv		α	
1,3	
GalNAc		 GlcNAc		Fuc		 Gal		
α	
1,2	
α	
1,2	
β	
1,3	
α	
1,3	
When comparing the O-antigen structures of all the serovars containing the family IV genes all 
but the Cubana serovar contained a mannose moiety and all but the O:7 group contained a 
galactose moiety (table 3). Importantly, there was no common sugar between the O-antigen 
structures. As the GtrC protein is predicted to transfer a sugar molecule to a specific position 
this means that either some or all of the core O-antigens need a further modification to provide a 
common target for GtrC(IV). On the other hand, the diversity in O-antigen structures could 
indicate that the target of the GtrC(IV) is not the O-antigen, which would mean that the gtr(IV) 
genes are not restricted to a particular O-antigen group. In table 3 the list of the other gtr genes 
contained within the strains showed that the family IV genes shared a genome with all six other 
families at some point. But in some strains they were found to be the only gtr gene within that 
genome. 
Table 3: Family IV strains' gtr composition and their O-antigen group and structure 
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3.3 ANALYSIS OF THE FAMILY IV GTRA PROTEIN 
 
GtrA has been shown to be a hydrophobic protein with four transmembrane domains (Korres et 
al., 2005). It is proposed to be the UnDP-glucose translocase, which flips the UnDP-glucose 
across the membrane so that it can be accessed by GtrC (Nair et al., 2011). To get a better 
understanding of the function of the family IV operon a bioinformatics analysis of the GtrA(IV) 
proteins was done. This analysis aimed to determine whether the function of GtrA(IV) is as a 
UnDP-glucose translocase and how its AA sequence relates to GtrA proteins from operons with 
a known function. For example the family I and III operon’s proteins are known to modify the 
LPS by adding a glucose molecule onto the O-antigen (Bogomolnaya et al., 2008) (Young et al., 
1964).  
 
All family IV GtrA AA sequences were aligned using the Cobalt Constraint-based Multiple 
Protein Alignment tool. The alignment (figure 4) shows the family IV GtrA proteins have an 
almost identical AA sequence with only two points having a variable AA. For this reason, only 
one sequence, from S. Typhimurium str. LT2, was used in further bioinformatics analysis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Alignment of GtrA(IV) AA sequences. 
After each sequence is the name of the serovar and strain the sequence belongs to. The numbers 
either side of the sequences is the first and last AA number in that block. Numbers in grey within 
the sequence represents AA that are not shown and indicates how many. Red residues indicate that 
the AA is the same across all sequences and blue means that the AA changes across the sequences.  
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3.3.1 Functional analysis of family IV GtrA 
 
A BLASTp analysis was used to identify proteins with similar AA sequence to the family IV 
GtrA protein so that a possible function could be identified. The search brought up many 
glucosyl translocases and bactoprenol-linked glucosyl translocases with high sequence identity 
to GtrA. Functional regions of the protein were identified using InterPro (Mitchell et al., 2014). 
This program identified a domain, which spans the majority of the protein, belonging to a GtrA-
like family of proteins that trans locates undecaprenyl phosphate linked glucose (UndP-Glc) 
across the cytoplasmic membrane. These results match with the proposed function of GtrA as a 
bactoprenol-linked glucosyl translocase.  
 
3.3.2 Transmembrane domain analysis of family IV GtrA  
 
As GtrA proteins are predicted to be membrane proteins so that they can bind a sugar molecule 
and flip it across the membrane to be accessed by GtrC the GtrA(IV) protein was analysed to 
see if it has any transmembrane domains (see section 2.16 for methods). Like other GtrA 
proteins transmembrane domains (Korres et al., 2005), GtrA(IV) had four transmembrane 
domains (figure 5) with three cytoplasmic and two periplasmic loops. The transmembrane 
domains of the family I and III GtrA proteins also showed the same structure (figures not 
shown).   
 
 
 
 
 
 
 
Figure 5: Transmembrane domain prediction of GtrA(IV). 
Produced using TMHMM Server v. 2.0. The red lines show the transmembrane regions while pink 
and blue indicate regions outside and inside the cell respectively. The y axis shows the probability 
that the prediction is correct and the x axis gives the AA number.  
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Heidelberg str. SL476_IV
Infantis strain 1326/28_IV
Agona str. SL483_IV
Choleraesuis str. SC-B67_V
Typhimurium DT104_I
Newport str. SL254_VII
Agona str. SL483_III
Paratyphi A str. AKU_12601_I
Paratyphi C strain RKS4594_VI
Paratyphi A str. ATCC 9150_III
Choleraesuis str. SC-B67_VI
Infantis_V
Gallinarum str. 287/91_III
Heidelberg str. SL476_IV
Infantis strain 1326/28_IV
Agona str. SL483_IV
Choleraesuis str. SC-B67_V
Typhimurium DT104_I
Newport str. SL254_VII
Agona str. SL483_III
Paratyphi A str. AKU_12601_I
Paratyphi C strain RKS4594_VI
Paratyphi A str. ATCC 9150_III
Choleraesuis str. SC-B67_VI
Infantis_V
Gallinarum str. 287/91_III
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
Figure 6: A comparison of GtrA proteins AA sequence from different families. 
A. Is a phylogenetic tree created from the alignment of GtrA proteins (figure 3B) using the neighbor 
joining method. The blue nodes indicate each sequence used in the alignment and the name of the 
serovar and strain and the family the protein is from is given next to each node. B. Is an alignment of 
GtrA AA sequences from 6 different gtr families. After each sequence is the name of the serovar and 
strain the sequence belongs to and which gtr family it came from. The numbers either side of the 
sequences is the first and last AA number in that block. Red residues indicate that the AA is the same 
across all sequences and blue means that the AA changes across the sequences. The blue lines 
underneath the sequences indicate the transmembrane regions of the family IV GtrA protein. 
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3.3.3 Comparison of family IV GtrA with other family GtrA proteins 
 
To compare GtrA(IV) to GtrA proteins of the other gtr families AA sequences from family I to 
VII were aligned, excluding family II. Family II functions as an acetyl transferase and the GtrC 
protein does require GtrAB for activity (Kintz et al., 2015). Before this, every GtrA AA 
sequence was aligned individually within their family. This analysis showed that within families 
the GtrA AA sequence is very conserved (figures not shown). To represent all variations in a 
family’s GtrA sequences two to three sequences were taken from each family and used in the 
alignment in figure 6B. A phylogenetic tree was also generated from the alignment using the 
neighbor joining method (figure 6A).  
 
Figure 6B showed that the family IV AA sequences had the most changes from the consensus 
sequences.  The coloured regions indicated where the sequences had some conservation where 
red indicated a region conserved across all of the proteins and blue residues showed where some 
proteins have a change in AA. When studying the blue regions it is clear that the majority of 
AA differences came from the family IV sequence. Many of the AA changes, outside of 
predicted transmembrane regions, were changes in a property, mainly between hydrophobic and 
neutral. The phylogenetic tree produced from the alignment, where the family IV proteins were 
clearly the most distant family, supported the differences seen in family IV sequences. The tree 
also shows that the GtrA proteins of the other families had mixed together and didn’t cluster 
into one group like the family IV proteins did, which is consistent with what Davies et al., saw 
when analysing the phylogenetic relationship between the gtr families. This observation could 
indicate that the family IV proteins have a function that is distinct from the other GtrA proteins 
for example they might be binding a different sugar to glucose.  
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3.4 ANALYSIS OF THE FAMILY IV GTRB PROTEIN 
 
GtrB proteins have been previously shown to have two transmembrane domains (Korres et al., 
2005) and its proposed function is as a glucosyl transferase, which transfers glucose from UDP-
glucose to UnDP-glucose so that it can be flipped across the membrane by GtrA (Nair et al., 
2011). As before, the purpose of this bioinformatics analysis is to establish whether GtrB(IV) 
functions as a glucosyl transferase and how its AA sequence relates to GtrB proteins from other 
gtr families.  
 
 
` 
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The family IV GtrB AA sequences were aligned (figure 7) using the Cobalt Constraint-based 
Multiple Protein Alignment Tool (Papadopoulos and Agarwala, 2007b). The family IV GtrB 
proteins had the same AA sequence apart from four points where the residue varied between 
two AA. Because the sequences were so similar only one sequence was used in further 
bioinformatics analysis of GtrB. The AA sequence used was from S. Typhimurium LT2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7: An alignment of GtrB(IV) AA sequences. 
After each sequence is the name of the serovar and strain the sequence belongs to. The numbers either 
side of the sequences is the first and last AA number in that block. Red residues indicate that the AA is 
the same across all sequences and blue means that the AA changes across the sequences. The blue line 
indicates the glucosyl transferase 2-like domain identified by Interpro (Mitchell et al., 2014). 
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3.4.1 Transmembrane domain analysis of family IV GtrB  
 
Based on their proposed function GtrB proteins are predicted to be membrane proteins. 
GtrB(IV) was analysed to see if it had any transmembrane domains (see section 2.16.). 
GtrB(IV) had two transmembrane domains (figure 8). The loop between them was in the 
periplasm with the c-terminal end and long N-terminal end in the cytoplasm. This 
transmembrane structure is the same as other GtrB transmembrane structures observed 
previousely (Korres et al., 2005). The transmembrane domains of the family I and III GtrB 
poteins, which are known to glycosylate the O-antigen (Bogomolnaya et al., 2008) (Young et 
al., 1964), also show that same structure as seen in figure 8 (figures not shown).     
 
 
 
 
 
 
 
 
 
 
3.4.2 Functional analysis of family IV GtrB  
 
A BLASTp analysis was carried out to identify AA sequences similar to the family IV GtrB 
protein. BLASTp analysis matched GtrB with bactoprenol glucosyl transferase proteins with a 
high sequence identity. Interpro (Mitchell et al., 2014) identified a glycosyl transferase 2-like 
domain (figure 4) which is a domain found in a diverse family of glycosyl transferases that 
transfers UDP-glucose to a range of substrates.   
Figure 8: Transmembrane domain prediction of GtrB(IV). 
Produced using TMHMM Server v. 2.0. The red lines show the transmembrane regions while pink 
and blue indicate regions outside and inside the cell respectively. The y axis shows the probability 
that the prediction is correct and the x axis gives the AA number.  
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Figure 9: Alignment of GtrB AA sequences from 6 different Gtr families. 
After each sequence is the name of serovar and strain the sequence belongs to and the gtr family it came 
from. Numbers either side of the sequences is the first and last AA number. Red residues indicate the 
AA is the same across all sequences and blue means the AA changes across the sequences. The blue 
lines underneath the sequences indicate the transmembrane regions of the family IV GtrB protein. 
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Agona str. SL483_IV
Choleraesuis str. SC-B67_IV
Cubana str. CFSAN002050_IV
Heidelberg str. SL476_IV
strain YU39_IV
Typhimurium DT104 _I
Paratyphi A str. AKU_12601_I
Gallinarum str. 287/91_III
Paratyphi A str. ATCC 9150_III
Agona str. SL483_III
Newport str. SL254_VII
Choleraesuis str. SC-B67_VI
Infantis_VI
Infantis_V
Choleraesuis str. SC-B67_V
Choleraesuis str. SC-B67_V
Agona str. SL483_IV
Choleraesuis str. SC-B67_IV
Cubana str. CFSAN002050_IV
Heidelberg str. SL476_IV
strain YU39_IV
Typhimurium DT104 _I
Paratyphi A str. AKU_12601_I
Gallinarum str. 287/91_III
Paratyphi A str. ATCC 9150_III
Agona str. SL483_III
Newport str. SL254_VII
Choleraesuis str. SC-B67_VI
Infantis_VI
Infantis_V
Choleraesuis str. SC-B67_V
Choleraesuis str. SC-B67_V
3.4.3 Comparison of family IV GtrB with other family GtrB proteins 
 
An alignment of all the GtrB proteins was done to compare GtrB(IV) with GtrB proteins from 
other families. GtrB proteins used in the alignment were picked using the same method as with 
GtrA. A phylogenetic tree was also generated from the alignment using the neighbor joining 
method.  
 
Figure 10 showed that the family IV AA sequences had the most changes from the consensus 
sequences as the majority of AA differences, shown in blue, came from the family IV sequence. 
Many of the AA changes, outside of predicted transmembrane domains, were changes in a 
property, mainly between hydrophobic and neutral or negative to neutral. This difference in 
sequences is supported by the phylogenetic tree produced from the alignment (figure 9) where 
the family IV proteins a clearly the most distant family. Similarly to GtrA(IV) this observation 
could indicate that the family IV GtrB proteins have a function that is distinct from the other 
GtrB proteins.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Phylogenetic tree of GtrB proteins. 
Created from the alignment of GtrB proteins (figure 10) using the neighbor joining method. 
The blue node indicates each sequence used in the alignment and the name of the serovar, 
strain and the family the protein is from, is given next to each node.  
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3.5 ANALYSIS OF THE FAMILY IV GTRC PROTEIN 
 
The GtrC protein is the protein that ensures specificity of the O-antigen modification and has 
been shown to add a particular sugar onto a certain moiety of the O-antigen using a specific 
linkage by GtrAB (Davies et al., 2013) (Young et al., 1964). For example the Gtr III proteins 
mediate the addition of a glucose molecule onto a galactose moiety at a C-4 position, this 
activity is specific to the GtrC(III) protein (Bogomolnaya et al., 2008). Therefore the proposed 
function of the GtrC proteins is as a glycosyl transferase that takes the sugar from GtrA that has 
been flipped across the membrane and transfers it onto the O-antigen in the periplasm. All GtrC 
proteins have 9-11 transmembrane regions and a long C-terminal tail in the cells periplasm, 
which is thought to have catalytic activity (Allison and Verma, 2000).  
 
The family IV GtrC AA sequences were aligned (figure not shown) using the Cobalt 
Constraint-based Multiple Protein Alignment Tool. Like GtrAB, the AA sequences of all the 
family IV GtrC proteins had almost identical AA sequence. There was only three points in the 
consensus sequence where the residue varied between two AA. Because the sequences are so 
similar only one sequence was used in further bioinformatics analysis of GtrC. The AA 
sequence used was from S. Typhimurium LT2.  
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3.5.1 Transmembrane domain analysis of family IV GtrC  
 
A transmembrane domain prediction (see section 2.16 for methods) was done using the GtrC S. 
Typhimurium LT2 sequence to look for transmembrane domains and a long C-terminal tail 
(figure 11). TMHMM transmembrane domain finder identified 9 transmembrane domains with 
a short N-terminal tail in the cytoplasm and a long 151 AA C-terminal tail in the periplasm.  
There were 4 periplasmic loops and 4 cytoplasmic loops. 
 
 
 
 
 
 
 
 
 
 
3.5.2 Functional analysis of family IV GtrC  
 
Interpro (see section 2.16. for methods) results for family IV GtrC found no functional domains. 
Although this result is not unexpected as the family III GtrC, which is known to modify the O-
antigen by transferring a glucose (Bogomolnaya et al., 2008), also has no predicted functional 
domains when analysed by Interpro. The BLASTp results for GtrC were not conclusive, no 
glucosyl transferase proteins were identified and the search findings mostly consisted of 
membrane proteins of unknown function from S. enterica. However there was one putative 
GtrC protein identified from Salmonella phage epsilon34 and they had a low sequence identity 
of 30%. This protein has been found directly downstream of proposed gtrAB genes. Although 
its function hasn’t been proven the epsilon34 bacteriophage is known to modify Salmonella’s 
surface polysaccharide by adding glucose onto a galactose residue (Wright, 1971) (Villafane et 
al., 2008). When this protein is analysed using Interpro no functional domains are found.  
Figure 11: Transmembrane domain prediction of GtrC(IV). 
Produced using TMHMM Server v. 2.0. The red lines show the transmembrane regions while 
pink and blue indicate regions outside and inside the cell respectively. The y axis shows the 
probability that the prediction is correct and the x axis gives the AA number.  
  49 
Choleraesuis str. SC-B67_VI
Infantis_VI
Choleraesuis str. SC-B67_V
Choleraesuis str. SC-B67_V
Infantis_V
Newport str. SL254_VII
Paratyphi A str. ATCC 9150_III
Dublin str. CT_02021853_III
Heidelberg str. SL476_IV
Ouakam strain GNT-01_IV
Choleraesuis str. SC-B67_IV
Heidelberg str. SL476_I
Typhimurium DT104_I
Paratyphi A str. AKU_12601_I
It may be the case that the epsilon 34 phage causes a modification to host bacterial O-antigen, 
which is the same as the modification mediated by the family IV proteins as they have some 
sequence identity in their GtrC. However the sequence identity is only low and might be 
significant only if the sequence similarity is just within the family IV proteins. BLAST analysis 
within the Salmonella phage epsilon34 genome was done with GtrC proteins from the other 
families. This analysis showed that the family III GtrC protein had a 39% sequence identity, 
higher than the family IV GtrC protein. Therefore, the sequence identity could be due to a 
similarity in function as a sugar transferase rather than reflecting a specific function.  
 
3.5.3 Comparison of family IV GtrC with other family GtrC proteins 
 
An alignment of all the GtrC proteins was done to compare GtrC(IV) with GtrC proteins from 
other families. Before this, every GtrC AA sequence was aligned individually within their 
family. This analysis showed that within the families the GtrC AA sequence is very conserved 
(figures not shown). To represent all variations in a family’s GtrC sequences two to three 
sequences were taken from each family and used in the alignment in figure S2. A phylogenetic 
tree was also generated from the alignment using the neighbor joining method (figure 12).  
 
The alignment (figure S2) and the phylogenetic tree produced (figure 12) showed that the 
family IV GtrC protein is more closely related to the family I and III GtrC proteins than the 
other Gtr families and there is a higher sequence similarity between GtrC’s from family III and 
IV than between family III and family I.  
 
 
 
 
 
 
 
 
Figure 12: Phylogenetic tree of GtrC proteins. 
Created from the alignment of GtrC proteins from 6 families in figure A3.1 using the neighbor 
joining method. The blue node indicates each sequence used in the alignment and the name of 
the serovar and strain and the family the protein is from is given next to each node.  
  50 
A second alignment was done using only the family I, III and IV protein sequences so that their 
similarities could be more clearly seen (figure 13). The transmembrane regions of each family 
were plotted underneath the alignment: red, blue and orange for family I, III and IV 
respectively. The glucosyl transferase II domain within GtrC(I), predicted by InterPro (Mitchell 
et al., 2014), is indicated above the alignment by a green line. The glucosyl transferase II 
domain is found within the GtrC equivalent of Shigella phage SfII, which mediates the addition 
of a glucose molecule onto the third rhamnose of the Shigella flexner O-antigen (Mavris et al., 
1997). Alignments of the C-terminal tails of the proteins were also done and orange boxes 
highlighted clusters of conserved AA identified by these alignments.  
 
In figure 13 the coloured regions indicate that the sequences have some conservation where red 
indicates AA conserved across all of the proteins and blue residues shows that some proteins 
have a change in AAs. It is clear that the N-terminal part of the proteins, including the glucosyl 
transferase II domain within family I, have higher conservation than the C-terminal tail of the 
protein. This might indicate that the C-terminal tail is the specific part of the protein and relates 
to the position of the modification on the O-antigen repeating unit.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 13. Continued on the next page  
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Transmembrane regions cover a lot of the N-terminal covered by the glucosyl transferase II 
domain. The only region not covered by a transmembrane domain and containing clusters of 
conserved AA is between the first two transmembrane domains. This region has eight 
conserved AA. This could indicate that this region is involved in a glucosyl transferase activity 
that is common between all proteins, for example binding the glucose. The C-terminal domain, 
which has less sequence conservation than the N-terminal, still has four residues conserved 
across all proteins, which are spread across the C-terminal rather than clustered. But between 
the family III and IV C-terminal tail there are two large clusters of conserved AA 
 
 
 
Figure 13: Alignment of GtrC AA sequences from Gtr families I, III and IV. 
After each sequence is the name of the serovar and strain the sequence belongs to and which gtr 
family it came from. The numbers either side of the sequences are the first and last AA number in 
that block. Numbers in grey within brackets represents AA that are not shown and indicates how 
many. Lower case AA in grey show low-complexity sequences that have been filtered out when 
building the alignment. The coloured regions indicate that the sequences have some conservation 
where red indicates AA conserved across all of the proteins and blue residues shows that some 
proteins have a change in AAs. The transmembrane regions of each family were plotted 
underneath the alignment: red, blue and orange for family I, III and IV respectively. The glucosyl 
transferase II domain within GtrC(I), predicted by InterPro (Mitchell et al., 2014), is indicated 
above the alignment by a green line. Clusters of conserved AA in the C-terminal tail between the 
family III and IV proteins are highlighted by an orange box.  
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Figure 14: Alignment of glucosyl transferase proteins of known function. 
After each sequence the origin of the sequence is specified, the first five sequences are all from Salmonella genomes and the name of the serovar and strain the sequence belongs 
to and which gtr family it came from is indicated.  The numbers either side of the sequences are the first and last AA number in that block. Numbers in grey within brackets 
represents AA that are not shown and indicates how many. Lower case AA in grey show low-complexity sequences that have been filtered out when building the alignment. The 
coloured regions indicate that the sequences have some conservation where red indicates AA conserved across all of the proteins and blue residues shows that some proteins 
have a change in AAs. The transmembrane regions in the Shigella phage SfII glucosyltransferase are indicated in blue and the epsilon 34 GtrC protein’s transmembrane domains 
are indicated in orange. Transmembrane domains were predicted using TMpred (http://www.ch.embnet.org/software/TMPRED_form.html). Conserved AA that were identified 
in the alignment of GtrC proteins from family I, III and IV (figure 10) are are indicated with blue arrows. 
3.6 ANALYSIS OF KNOWN GLUCOSYL TRANSFERASE 
PROTEINS 
 
To identify AAs involved in binding the glucose molecule in a glucosyl transferase protein an 
alignment of known glucosyl transferase proteins was generated. The proteins used in the 
alignment were the family I and III proteins used in the previous alignments, the family VIII 
GtrC proteins from the Salmonella phage epsilon 34 and the GtrC equvelent, serotype-specific 
glucosyl transferase protein from the SfII Shigella phage.  
 
The alignment had one cluster of conserved AA at the N-terminal end of the proteins which 
might be involved in binding a glucose molecule. The AA cluster, indicated by arrows in figure 
11, were also present in GtrC(IV). Part of the cluster of conserved AA (figure 14) were covered 
by a predicted transmembrane domain in the Shigella phage SfII GtrC equivalent. But Glycine 
and aspartic acid, part of the cluster of AAs, were predicted to be in the periplasm in all GtrC 
proteins studied. This alignment could indicate that these two AA might be needed to bind a 
gluc
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3.7 CHAPTER CONCLUSION  
 
3.7.1 Summary and conclusion of the spread of the family IV genes and the O-
antigen structure of their serovars 
  
Analysis of the family IV serovar’s O-antigen structures showed that there is no common 
sugar between the serovars that contain them. This was reflected in the number of O-antigen 
groups that the family IV genes were found within. Unlike the other gtr families, who were 
found within a maximum of three O-antigen groups, family IV was found within eight 
different groups. This could suggest that the O-antigen is not the target of GtrC(IV). Or this 
could be because the family IV genes provide a selective advantage to the bacteria and has 
been well maintained within populations.  
 
If GtrC(IV) is modifying the O-antigen at a specific moiety then further modifications to of 
all or some of the O-antigens basic structure would be needed. For example, if the Cubana 
serovar’s O-antigen had a manose modification added to its repeating unit structure this 
would mean that there was a common O-antigen sugar between the serovars. Other gtr 
families could be providing a common modification to the basic O-antigen structure. 
Although, as some family IV serovars only contain the family IV gtr genes, this would not be 
the case for all serovars. As all but the O:7 group of serovars contain a galactose moiety it 
may be the case that the family V or VI gtr genes, contained within the serovars of group O:7, 
are mediating the addition of a galactose residue onto the O-antigen.  
 
Alternatively, the difference in O-antigen structures could reflect that the O-antigen is not the 
target of the family IV proteins and they are targeting something else in the periplasm. Or it 
could be that GtrC(IV) has a broader range of activity and does not have a specific target. 
Both of these hypotheses could explain why the family IV genes are in a largest number of 
serovars and O-antigen groups as their activity would not be restricted by O-antigen structure.  
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Another contributing factor to their wide spread across serovars may be because they are 
required for persistence within a host (Chaudhuri et al., 2013) and for this reason have been 
well maintained within a strains genome.  
3.7.2 Summary and conclusion of the function of the family IV proteins 
 
The bioinformatics analysis of the family IV proteins has shown that they are all 
transmembrane proteins (figures 2., 5. and 8.) and seem to function broadly as predicted 
based on the model of the Gtr proteins activity. Based on the BLASTp InterPro results the 
GtrA protein is predicted to function as a glucosyl translocase that translocates UndP-Glc 
across the cytoplasmic membrane. GtrB is predicted to function as a glycosyltransferase that 
transfers UDP-glucose to a range of substrates. Based on GtrC’s sequence similarity with the 
family III and I GtrC proteins it is predicted to function as a glucosyl transferase as both 
families are known to add a glucose onto the O-antigen repeating unit.  
 
The alignments of six of the families GtrA and GtrB proteins (figures 3B. and 7.) showed that 
there was a lot of conservation between their AA sequences. This is expected, as these are the 
non-specific proteins that are expected to have broadly the same function. However, the 
family IV GtrA and GtrB proteins were both shown to have the most AA differences in its 
sequence compared to the other family GtrAB proteins whose sequences were more 
conserved with each other. This could clearly be seen in the phylogenetic trees generated 
from the protein’s alignments (figures 3A. and 6.). This could be because the functions of the 
family IV proteins are slightly different from the other family IV GtrAB proteins. For 
example, they might bind a different sugar that isn’t glucose. This hypothesis is supported by 
the observation that the family IV operon has not recombined with other family operons, 
unlike the other gtr families (Davies et al., 2013). If GtrAB(IV)’s function was different then 
recombination would make a non functional operon.  
 
In contrast to the GtrAB(IV) proteins the GtrC(IV) protein had a higher sequence similarity 
with GtrC(I) and GtrC(III) than the other families. The GtrC(IV) and Gtr(III) protein were 
very closely related and had a higher sequence similarity than GtrC(III) and GtrC(I). This is 
interesting as both families I and III are known to mediate the addition of glucose onto 
different positions on a galactose moiety.  
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Therefore, the GtrC(IV) may have a very similar function to GtrC(III) and also bind and 
transfer a glucose sugar onto a galactose moiety. The galactose sugar is part of the core 
structure of all but the O:7 group of serovars occupied by the family IV genes. All of these 
O:7 group serovars contain the family V and VI gtr genes. It is not known what modifications 
the family V and VI proteins make to the O-antigen and could possibly be a galactose sugar, 
providing a common sugar amongst the O-antigens of the family IV serovars.  
 
The alignment in figure 13 of family I, III and IV GtrC proteins showed clusters of conserved 
AA between all three proteins located between the first two transmembrane domains. 
Between all three proteins the C-terminal tail had less sequences conservation. This could be 
because the C-terminal tail is involved in specifically adding the sugar onto the O-antigen 
repeating unit whilst the clusters of conserved AA at the N-terminal could be involved in 
binding the sugar. For family I and III this in known to be the same sugar, a glucose, therefore 
there is expected to be a conserved glucose binding region. The conserved AA between the 
first two transmembrane domains in the alignment of GtrC proteins from families I, III and VI 
(figure 13), could be the AA necessary for binding a glucose molecule. As the family IV 
protein also shows conserved AA within this region it may be the case that GtrC(IV) also 
binds a glucose.  
 
To strengthen this theory, glycosyl transferase proteins that are known to bind a glucose 
molecule, including the family I and III proteins, were aligned (figure 14). This alignment had 
just one clustering of conserved AA, which is likely to be the AA involved in binding the 
glucose molecule as this is the functional commonality between these proteins. The alignment 
identified two conserved AA predicted to be in the periplasm in all GtrC proteins studied in 
section 3.5. and could be involved in binding the glucose molecule. These AA are also 
conserved in the periplasm of GtrC(IV), which could indicate that it is also binding a glucose 
molecule.  
 
The C-terminal tails of the family III and IV proteins has two clusters of conserved AA that 
aren’t present in the family I proteins. This could indicate that the family III and IV proteins 
have a very similar function. The only difference between family I and III GtrC proteins is 
that GtrC(I) mediates a 1,6 linkage and GtrC(III) mediates a 1,4 linkage of glucose to the 
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galactose moiety. Therefor, it may be that family IV makes the same linkage as family III and 
mediates the addition of a glucose to a galactose sugar at a 1,4 position.    
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4. EXPRESSION OF THE FAMILY IV GTR 
OPERON UNDER INFECTION RELEVANT 
CONDITIONS 
 
 
The family IV gtr genes have been shown to be required for persistence within a host 
(Chaudhuri et al., 2013) but we know nothing about what advantage they provide during an 
infection. To start to answer this question it would be useful to know at what point the operon 
is expressed when the bacteria is infecting a host. This chapter investigates whether any 
infection relevant conditions cause an up regulation in the family IV gtr genes expression. 
This information could give an indication of when the family IV Gtr proteins are needed 
during the infection process (discussed in section 1.4.2.).  
 
The expression of the family IV gtr genes from a constitutive Ptac promoter in a basal S. 
Typhimurium strain does not cause a detectable modification of the LPS (Davies et al., 2013). 
One of the reasons for this may be because the family IV genes constitutively expressed 
mRNA is not being translated into protein due to post transcriptional controls under normal 
laboratory growth conditions. If the protein’s function is important for growth and persistence 
during an infection then they may not be needed when grown under normal laboratory 
conditions. For example, the activity and production of the proteins may be energetically 
costly for the cell so their translation is restricted to times when they are need for persistence 
within a host. If the strain constitutively expressing the family IV genes was grown under 
conditions that triggered up regulation of the operon then this is likely to be a condition under 
which the cell would translate the transcript into protein. These conditions could then be used 
when growing up strains that are constitutively expressing the gtr(IV) genes and analysing 
their LPS banding pattern to look for modifications of the O-antigen.  
 
A recent study (Kröger et al., 2013) has done a global transcriptome analysis of S. 
Typhimurium under various infection relevant conditions using an RNAseq method. The 
results for the family IV gtr operon showed that the point at which gtrA had the highest 
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recorded number of transcripts was under NO shock and gtrC is also up regulated under NO 
shock. Another condition where up regulation of gtrC is seen is pH3 shock where gtrC’s 
highest level of up regulation is seen as well as one of the highest transcript numbers.  
 
4.1 EXPRESSION OF FAMILY IV GTR GENES UNDER 
PH3 SHOCK 
 
One of the aims of these experiments was to gain an insight into when the family IV genes are 
needed during infection by testing whether certain infection relevant conditions cause up 
regulation of expression. This experiment tested whether pH3 shock would cause up 
regulation of the family IV genes. pH3 conditions are relevant to infection because this is the 
pH of the gastric system of humans (Goktepe et al., 2005) and other common hosts of S. 
Typhimurium like pigs (Crévieu-Gabriel et al., 1999; Wilkins et al., 2010) is around pH3. The 
Kroger et al., (Kröger et al., 2013)data showed that gtrC and gtrA had some of the highest 
transcript levels under pH3 shock compared to the other conditions measured. Also, the data 
produced by Chaurdhuri et al., (Chaudhuri et al., 2013), which showed that the family IV 
genes were important for persistence within a host, found that gtrAB were only necessary for 
persistence in the hosts that were orally infected, cows, chickens and pigs. The mouse, the 
host where gtrAB were not required for persistence, was infected intravenously.  
  
 To measure the levels of gene expression under pH3 shock total RNA was extracted from a 
culture of wild type S. Typhimurium (strain 380) that had been shocked with pH3 and from a 
control culture that had been kept at pH7 (see sections 2.11. and 2.13. for pH3 shock and 
RNA extraction methods). Reverse transcription (section 2.14.) was then performed on the 
RNA samples and the resulting cDNA was used from RT-qPCR analysis (section 2.15.). 
Comparative RT-qPCR was used and two genes that had a constant expression across 
conditions of pH7 and pH3 were used as reference genes. The two reference genes were yibT 
and modF. These genes were picked from S. Typhimurium’s global transcriptome data which 
showed transcript levels under various conditions (Kröger et al., 2013). Both yibT and modF 
were chosen because their expression levels were constant between conditions of pH7 and 
pH3.  
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Relative RT-qPCR uses the levels of the reference gene’s transcript to normalize the levels of 
the transcript of interest between the treated and control samples. This gives a value of 
expression level as relative quantification (RQ). This is because we assume the reference 
gene’s expression will not change between the treated and control, as mentioned above the 
reference genes expression was constant between pH7 and pH3 conditions. Consequently, we 
can only compare between samples where the only difference between them is the conditions 
controlled for by the reference genes. When other conditions vary, such as time, only fold 
change can be compared between samples. The relative quantification of the control sample is 
always put to 1 as this sample represents a control level of gene expression which is expected 
to stay constant.  
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4.1.1 Expression of family IV gtrC ten minutes after pH3 shock 
 
Figure 15 shows gtrC expression measured by RT-qPCR of samples that were acidified to 
pH3 and grown for 10 min compared to samples that were kept at pH7. The two biological 
replicates did not show the same trend in expression. Replicate 1 pH3-shocked sample had a 
slightly higher but insignificant change in gtrC expression level (a fold increase of 1.24) 
compared to the sample kept a pH7. In contrast, replicate 2 showed a significant decrease 
(3.06 fold change) in gtrC expression level under pH3 shock compared to the level of 
expression under pH7 conditions.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15: gtrC expression under pH3 shock. 
Relative expression levels measured by RT-qPCR of gtrC under pH3 shock and the control 
condition of pH7 in biological replicates. Red bars relate to pH3 condition and blue bars to pH7 
condition. The y-axis shows relative quantification of gtrC relative to the reference gene levels. 
The x-axis indicates which biological replicate the samples are from. Values in the boxes below 
the x-axis give the fold change in relative gtrC levels between pH3 and pH7 treated samples in 
the biological replicate. A + in front of the fold change value indicates the levels of gtrC under 
pH3 shock have increased compared to the levels at pH7 and a – means they have decreased.  
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4.1.2 Expression of family IV gtrA and gtrC at multiple time points under pH3 
shock 
 
The variation between the biological replicates in figure 15 could have been due to small 
differences in the time each sample’s RNA was protected (see section 2.13. for methods) or 
fixed in the sample. Some bacterial mRNA transcripts can have a half life as short as 40 sec 
(Richards et al., 2008). The following experiment was designed so that RNA was extracted 
from a time course of samples to see how the levels changed over a short period of time. 
RNA was extracted at 5, 10 and 15 minute intervals.  
 
The gtr(IV) operon was expected to be transcribed together from a promoter upstream of 
gtrA. The Kroger et al., (Kröger et al., 2013)data showed that there were differences in the 
gtrABC transcript levels of the family IV operon under specific conditions. To compare the 
levels of expression of the family IV operon’s genes, both gtrC and gtrA expression levels 
were measured.  
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Figure 16: The relative expression levels of gtrC and gtrC under pH3 shock. 
Expression was measured by RT-qPCR, under pH3 shock and the control condition of pH7 in 
two biological replicates at 5, 10 and 15 minutes after shock. The red bars relate to the pH3 
condition and the blue bars relate to the pH7 condition. The y-axis shows the relative 
quantification of gtrC, which is relative to the reference gene levels. The x-axis gives the 
number of minutes after pH3 shock the samples were taken. The values in the boxes below the 
x-axis give the fold change in relative gtrC levels between the pH3 treated and pH7 treated 
samples in the biological replicate. A + in front of the fold change value indicates the levels of 
gtrC under pH3 shock have increased compared to the levels at pH7 and a – means they have 
decreased. The bottom boxes indicate which biological replicate the samples were taken from. 
A. gtrC expression under pH3 shock: shows the level of expression of the gtrC transcript. B. 
gtrA expression under pH3 shock: shows the level of expression of the gtrA transcript. 
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In figure 16A there was no significant fold increase in expression at pH3 compared to pH7. 
Both biological replicate 1 and 2 showed that gtrC fold change in expression between pH3 
and pH7 conditions increased over the 15-minute period. In both replicates the 5-minute 
sample shows the biggest fold decrease in expression at pH3. In replicate 1 the fold change at 
10 min stayed constant with the 5 min sample. The sample taken at 10 minutes in replicate 2 
showed no fold change in gtrC expression between conditions of pH3 and pH7. At 15 
minutes both replicate samples had no fold change in expression showing that gtrC 
expression was similar under both conditions. (Figure 16A) 
 
 The results in figure 16A show that, in both samples, the relative level of gtrC drops after 
pH3 shock but returns to the initial relative level after 15 min and that gtrC fold change in 
expression between pH3 and pH7 conditions can change over a period of 5 minutes. This 
supports the conclusion that the differences seen between the biological replicates in figure 15 
may have been due to difference is the time taken to protect the RNA. 
 
The level of gtrA (figure 16B) in biological replicate 1 consistently had a significant fold 
decrease in expression under pH3 conditions compared to pH7, at 10 min there was an 11-
fold decrease in gtrA expression. In Biological replicate 2 the 5 minute and 10 minute sample 
did not have a significant change in gtrA expression between conditions of pH3 and pH7. At 
15 minutes gtrA expression has decreased 2.13 fold in the pH3 shocked sample compared to 
the pH7 sample. There is a difference in the pattern of gtrA expression between the two 
biological replicates where biological replicate 1 showed a much bigger fold decrease of gtrA 
expression under pH3 than biological replicate 2, particularly in the 10 min sample. 
 
A comparison of figure 16A and 16B shows that in biological replicate 1 there was a large 
difference in the expression patterns of gtrA and gtrC. gtrA had a greater difference in 
expression levels between conditions of pH3 and pH7 compered to the change in gtrC 
expression levels. Comparing gtrA and gtrC in biological replicate 2 their trends in expression 
were mostly similar. But At 15-minutes gtrA’s expression under pH3 conditions had 
decreased compared to the expression under pH7, whereas gtrC expression didn’t changed 
between the two conditions. 
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4.2 EXPRESSION OF FAMILY IV GTR GENES UNDER 
NITRIC OXIDE (NO) SHOCK 
 
These experiments looked at whether NO shock could cause an up-regulation of the family IV 
gtr operon. It was seen from the Kroger et al., (Kröger et al., 2013) data that cultures grown 
under nitric oxide shock had a 3.76 fold increase of gtrA compared to a control growth 
condition. As discussed in section 1.4.2., when Salmonella is infecting a host it will 
experience conditions of NO shock from the immune response mounted against it.  
 
4.2.1 Expression from the family IV gtrA upstream region under NO shock 
 
The effect of NO shock on expression from the up stream region of gtrA was studied by 
cloning the upstream region in front of the lacZ gene, a transcriptional reporter, and 
measuring the levels of LacZ produced using a beta-galactosidase assay (see section 2.12. for 
methods). The Conditional-Replication, Integration, Excision, and Retrieval (CRIM) vector 
(Haldimann and Wanner, 2001) was used to integrate the family IV regulatory region-lacZ 
construct into the genome of S. Typhimurium (see section 2.8 for methods). Strain 917 was 
created with a 355bp region upstream of the lacZ gene intograted into the chromosome. The 
355bp region included the upstream region of gtrA and overlapped the gtrA start site.  
 
Strain 917 was grown in Salmonella pathogenicity island II inducing media (InSPI2) media 
and shocked with NO at OD600 0.3 by the addition of spermine NONOate (see section 2.10. 
for methods). Before the addition of NO, the culture was split and one half was taken as a 
control, which received no NO shock. Samples were taken just before NO addition. Then 
again at 20 min after, which is when samples were taken for RNAseq analysis by Kroger et 
al., (Kröger et al., 2013) , and finally 60 min after NO addition to look for any long-term 
effects of the operons expression. Three biological replicates were used in this experiment 
and four technical replicates were taken from each biological replicate.  
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At 20 minutes after NO shock the level of beta-galactosidase expression, measured in Miller 
units, in the treated sample has increase compared to the control sample but the difference 
between their means is not significant (figure 17). The fold change in expression that was 
seen in the 20-minute sample was lower than the results reported by Kroger et al., (Kröger et 
al., 2013) who found a 3.76 fold increase in gtrA expression. At 60 minutes after NO shock 
beta-galactosidase expression in the treated sample has decreased compared to the control 
sample with a significance of p=0.043 (figure 17).  
 
 
 
 
 
Figure 17: Expression of gtrA under NO shock measured through the lacZ reporter 
gene. 
The level of beta-galactosidase measured in Miller units produced from strain 917 is shown on the y-
axis. Strain 917 has the lacZ gene down stream of a 355pb gtrA(IV) regulatory region integrated into 
its genome.  On the x-axis is the number of minutes after NO shock the sample was taken. 0 minutes 
indicates it was taken just before NO addition. The blue bars indicate the sample was shocked with 
NO and the red bars indicate a control sample that received no NO shock. A t-test was performed on 
the data from the 20-minute sample and the 60-minute sample with a significance of p<0.05. The P 
value is above the corresponding bars.  
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4.2.2 Expression of family IV gtrA under NO shock 
 
To determine whether the increase seen in figure 17 at 20 min after NO shock is significant 
more biological replicates would need to be done. But the increase was lower than expected 
based on the Kroger et al., (Kröger et al., 2013) results, which showed a 3.76 fold increase in 
gtrA expression under NO shock. This could have been due to the differences in the beta-
galactosidase assay and the RNAseq methods used by Kroger et al., (Kröger et al., 2013). 
RNAseq measures the genes transcript level whereas a beta- galactosidase assay is measuring 
protein which will have a lag in production compared to its corresponding mRNA. Therefore, 
a time point slightly after 20 minutes might have shown an increase in beta-galactosidase. 
Another reason for not seeing the increase in expression that was expected could have been 
that the region cloned in front of the lacZ gene did not contain the whole promoter region. To 
overcome this problem RT-qPCR was used. RT-qPCR directly measures the mRNA level of a 
gene transcribed from the chromosome so will show the actual level of transcript available to 
be translated into protein.  
 
A culture of wild type S. Typhimurium (strain 380) was grown in InSPI2 media and shocked 
with NO at OD600 0.3 by the addition of spermine NONOate (see section 2.10. for methods). 
Before the addition of NO, the culture was split and one half was taken as a control, which 
received no NO shock. Samples from both the control and the treated sample were taken at 20 
minutes after shock. Two biological replicates of this experiment were done. RNA was 
extracted from these samples and reverse transcription was performed before the resulting 
cDNA was used in an RT-qPCR experiment. The level of gtrA’s transcript was measured in 
this experiment. Out of the three family IV genes gtrA had the highest absolute transcript 
level in S. Typhimurium’s global transcriptome data (Kröger et al., 2013).  
 
Comparative RT-qPCR was used and two reference genes were chosen using the Kroger et 
al., (Kröger et al., 2013) data to ensure there expression levels were constant between 
conditions of NO shock and a control condition. The two reference genes chosen were kdgR 
and STM1575.  
 
 
  16 
0"
0.2"
0.4"
0.6"
0.8"
1"
1.2"
Biological"rep"1" Biological"rep"2"
control"
NO"shock""
Fold"
change" <3.01" <1.11"
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In figure 18, biological replicate 1 and 2 do not follow the same pattern of gtrA expression. In 
biological replicate 1 gtrA expression under NO shock is 3 fold less than gtrA expression in 
the control condition, whereas there is almost no change in gtrA expression levels in 
biological replicate 2. The pattern of expression of gtrA (figure 18) and expression from the 
gtrA upstream region (figure 17) are different. This could be due to the differences in the 
techniques used. The region cloned in front of the lacZ gene could be missing important 
regulatory regions. Also, the beta-galactosidase assay will not have accounted for any post-
transcriptional regulation as the assay only measures the level of transcription from the gtrA 
upstream region and not the gtrA transcript unlike RT-qPCR.  
Figure 18: Expression of gtrA under NO shock measured by RT-qPCR 
Relative expression levels, measured by RT-qPCR, of gtrA under NO shock and the control 
condition of no NO shock in two biological replicates. The red bars relate to the NO shock 
condition and the blue bars relate to the control condition. The y-axis shows the relative 
quantification of gtrA, which is relative to the reference gene levels. The x-axis indicates which 
biological replicate the samples are from. The values in the boxes below the x-axis give the fold 
change in relative gtrA levels between the NO shock and the control samples in the biological 
replicate. A + in front of the fold change value indicates the levels of gtrA under NO shock have 
increased compared to the levels at the control condition and – means they have decreased.  
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4.3 IS FAMILY IV GTRC BEING EXPRESSED 
INDEPENDENTLY OF THE OPERON PROMOTER? 
 
The global transcriptome study of S. Typhimurium (Kröger et al., 2013) also produced data 
showing the transcriptional start sites (TSS) of many S. Typhimurium genes. This was done 
using terminator 5’-phosphate dependent endonuclease, which was used to enrich a 
population of transcripts for primary transcripts. These transcripts were sequenced and this 
was used to identify the TSS. Two possible transcriptional start sites were identified within 
gtrB(IV) when the strain was grown in InSPI2 media (personal correspondence with Disa 
Hammerlof – exact positions of the TSS’s were not available). This indicates that gtrC may 
be expressed independently from the main family IV operon promoter.  
 
To confirm that there was expression from a promoter within gtrB a region of the gene 
thought to contain the promoter was cloned into the CRIM vector in front of the lacZ gene.  A 
581bp region within gtrB and overlapping the gtrC start site was amplified using high fidelity 
colony PCR. This region was then cloned into the CRIM vector in front of the lacZ gene (see 
section 2.5. and 2.6. for methods). The CRIM vector was then integrated into the S. 
Typhimurium (strain 79) genome at the attB phage insertion site making strain 944 (see 
section 2.8. for methods).   
 
A beta-galactosidase assay (section 2.12.) was performed using strain 944 to test the 
expression from the site within gtrB and a control strain, strain 81, that was the same as strain 
944 but had no region cloned in front of the lacZ gene. These two strains were cultured, in 
biological duplicates, in InSPI2 media to an OD600 of 0.3. Four technical replicate samples 
were taken from each culture to perform a beta-galactosidase assay.  
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AAGCGCTGAGTGGTTCTACAGGCTGCATAACAAAATCAGTACGCCAAAGATTGAAGAGAATGTCGGTGATTTT
CGATTGATGTCGCGCGAGATTGTAGAAAATATCAAGCTATTACCAGAACGTAACCTTTTCATGAAAGGTATACT
TTCATGGGTTGGAGGTCAAACAGATGTGGTCGAATATGCCCGTGCTGAACGTGTCGCAGGTAACTCAAAATTTA
ATGGCTGGAAACTCTGGAACCTGGCGCTGGAGGGGATTACAAGTTTTTCTACTTTCCCTTTGCGTATCTGGATG
TATATAGGAGTGAGCGTTTCTGCCCTCTCCCTGATATATGCCATGTGGATGATCATTGATAAATTGATGTGGGG
AAACCCTGTTCCTGGTTATCCTTCGCTTATGACCGCGATTCTCTTCTTAGGCGGCATCCAGCTTATCGGCATAGG
CATCATGGGTGAATATATCGGACGCGTTTACACGGAGGTGAAGCAAAGACCCCGCTATATCGTGAAAAACAAA
AAAACAATGATGGAATAATGAACACTATGCTCAAGATATTACCGAAAACGGCGATGATACTACT	
The graph in figure 19 shows that the amount of beta-galactosidase (measured in miller units) 
produced by strain 944 was nearly 7 folds more compared to the control strain. A 7-fold 
increase in expression indicates that the region inserted in front of the lacZ gene is promoting 
transcription. Two possible promoter region recognized by sigma 70 have been predicted 
within the 581bp region and are shown in figure 20.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Expression from TSS 
within gtrB(IV). 
The level of beta-galactosidase measured in 
miller units produced from strain 944 and 
strain 81. Strain 944 has the lacZ gene down 
stream of a 581pb region, taken from within 
gtrB(IV), integrated into its genome. Strain 
81 is the same as strain 944 but has no region 
cloned in front of the lacZ gene. On the x-
axis ‘within gtrB’ refers to strain 944 and 
‘control’ refers to strain 81.  
Figure 20: The 581bp region cloned in front of the lacZ gene. 
An 581bp region, taken from within gtrB and overlapping gtrC start codon, that was cloned in 
front of the lacZ gene to make strain 944. The underlined bases show that primer regions used to 
amplify the fragment. The red lettering indicates the gtrB stop codon and the blue indicates the 
gtrC start codon. The highlighted bases show two possible sigma70 -10 and -35 boxes, one set in 
yellow and the other in green. The sigma70 promoter regions were predicted using BPROM - 
Prediction of bacterial promoters (V. Solovyev, 2011). 
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4.4 CHAPTER CONCLUSION 
 
None of the results in this chapter have shown that there is an up regulation of the family IV 
gtr genes under pH3 or NO shock. After pH3 shock expression levels of gtrC and gtrA drop. 
After 15 minutes the expression of gtrC returned to the original level showing that the effect 
of the pH3 shock on gtrC expression is not sustained. Under pH3 and NO shock there was an 
indication that the promoter upstream of gtrA may have variable expression under certain 
conditions. As well as the main operon promoter, sites within gtrB were shown to promote 
transcription, which suggests that gtrC could be transcribed independently. This is supported 
by the results in section 4.1.2. which showed that gtrA and gtrC had different patters of 
expression. 
 
The results of this chapter that looked at the family IV genes up regulation under pH3 and NO 
shock have not been able to replicate the findings of the study carried out by Kroger et al., 
(Kröger et al., 2013). This could have been because of difference between the methods of 
RNAseq and RT-qPCR. The two methods quantify expression by measuring different things, 
RT-qPCR only measures part of the transcript whereas RNA-seq measures the full transcript. 
Also, they both use different units of measurement to describe levels of expression, which are 
obtained by different normalization methods that could have different biases attached. 
Relative RT-qPCR uses the reference genes to normalize the data and gives the units in 
relative quantification (RQ). RNAseq analysis generates results in units of transcripts per 
million (TPM). Measurements in TPM are obtained by normalizing the data against 
sequencing depth and average read length of the sequencing run and gene of interest length 
and (Wagner et al., 2012).  Therefore, relative RT-qPCR may have biases based on the 
expression of the reference gene whereas RNAseq will have biases based on the transcript 
pool of the sequencing run. This means that small fold changes in expression might not be 
reproducible between the two techniques.  
 
There was a difference in the expression pattern of gtrA, under pH3 shock, between the two 
biological replicates in figure 16B. gtrA had consistently low expression at pH3 compared to 
pH7 in biological replicate 1, whereas in biological replicate 2 the fold change in expression 
between pH3 and pH7 was small. The difference between the biological replicates could be 
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due to the promoter having variable levels of expression under either pH3 conditions or pH7 
conditions.  
 
Similarly, gtrA expression under NO shock (figure 18) was not consistent between the two 
biological replicates. Biological replicate 1 showed a 3-fold decrease in gtrA expression under 
NO shock whereas there was no change in expression in biological replicate 2. This could be 
due to the time taken for the RNA to be fixed in each sample. As seen in figure 16A the levels 
of RNA can change over a short period of time. Or these results could also be showing that 
there is a variable level of expression from the gtrA upstream promoter.   
 
As the gtrABC genes are together in an operon we would expect them to be expressed from 
the same promoter and therefor have the same expression pattern. However, the results in 
biological replicate 1 of figure 16A and 2B did not follow this assumption. The expression of 
gtrA has a higher decrease in expression under pH3 shock that gtrC compared to the control 
condition. The differences in these two genes patterns of expression could be due to the 
possible promoter region within gtrB. If this promoter responds differently to either pH3 or 
pH7 conditions then the expression pattern of gtrC will be different to gtrA’s expression.  
 
Section 4.3 looked at whether there was a promoter region within gtrB that could be 
promoting expression of gtrC separately from the main operon promoter. Figure 19 showed 
the amount of beta-galactosidase produced from a strain with the proposed regulatory region 
in front of the lacZ gene. The presence of the proposed regulatory region in front of the lacZ 
gene increased beta-galactosidase production by up to 7 fold compared to the control strain, 
which had no regulatory region in front of the lacZ gene. gtrC expression from a promoter 
independent of the main operon promoter helps to explain the results in figure 16A and 2B 
where there is a large difference in gtrA and gtrC’s expression patterns in biological replicate 
1. The promoter within gtrC may respond differently to the main promoter under certain 
growth conditions. This would mean the fold changes in gtrA and gtrC expression between 
two growth conditions could be different.  
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5. ARE MODIFICATIONS BY OTHER FAMILIES 
OF GTR PROTEINS NEEDED FOR GTR(IV) 
ACTIVITY? 
 
The constitutive expression of the family IV gtr genes from a Ptac promoter in a basal S. 
Typhimurium strain does not cause a detectable modification of the LPS (Davies et al., 2013). 
One of the reasons for this could be that further modifications of the basal O-antigen are 
needed to provide GtrC with a target for addition of a sugar. In a wild type strain of S. 
Typhimurium, and other Salmonella strains containing the gtr(IV) operon, there are other 
families of gtr operons present (Davies et al., 2013). The modifications made by these 
proteins could be needed to provide GtrC(IV) with a target. This chapter looks at the effect of 
family III O-antigen modification on gtrC(IV) activity in S. Typhimurium and at the effect of 
either family V or family VI O-antigen modifications on gtrC(IV) activity in S. Infantis.   
 
To study whether modifications by other gtr operons are needed for GtrC(IV) activity the 
following methods were used: LPS was extracted from strains and ran on a TSDS-PAGE gel 
to show the laddered pattern of varying lengths of O-antigen repeating units (see section 2.9. 
for materials and methods).  In a strain expressing no other O-antigen modifying genes the 
gtr(III), gtr(V) or gtr(VI) operon was expressed from the Ptac promoter in the chromosomal 
DNA. The family III genes were expressed in S. Typhimurium and the family V and VI genes 
in S. Infantis, which is where the genes are naturally found. The gtr(IV) operon was expressed 
from the lac promoter carried on the Plac22 vector and had been transformed into the three 
strains expressing a gtr operon from the Ptac promoter. These three transformed strains 
combined the expression of the family IV operon with another gtr family.  
 
The Plac22 vector expression system(Warren et al., 2000) is inducible as it carries the lacIq 
repressor gene, which binds the lac promoter and stops expression. IPTG is added to a culture 
to induce expression and works by binding the LacIq repressor protein, changing its 
conformation and preventing it from binding the lac promoter.  
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A strain expressing only gtr(III), gtr(V) or gtr(VI) from the Ptac promoter will be referred to 
as Gtr III, Gtr V or Gtr VI respectively or when referring to them as a collective, Ptac-Gtr will 
be used. The addition of +IV will be used to indicate the strain is also expressing gtr(IV) from 
the Plac22 plasmid or +Plac22 means the strain has been transformed with an empty Plac22 
vector which contains no gtr(IV) operon.  
 
As well as a comparison between Ptac-Gtr strains and Ptac-Gtr+IV strains a basal strain, one 
expressing no known O-antigen modifying genes, and a Ptac-Gtr+Plac22 strain were used as 
controls. Comparison of Ptac-Gtr with the basal strain shows sufficient modification of the O-
antigen by the gtr operon expressed from the Ptac promotor. The Ptac-Gtr+Plac22 strain 
controls for any effect the presence of the vector could have on the strains O-antigen that was 
not due to its expression of the gtr(IV) operon.  
5.1 DO MODIFICATIONS OF THE O-ANTIGEN BY THE 
FAMILY III, V OR VI PROTEINS PROVIDE A 
TARGET FOR FAMILY IV GTRC ACTIVITY? 
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5.1.1 Can Gtr family III modifications of the S. Typhimurium O-antigen 
provide family IV GtrC with a target for activity? 
 
The S. Typhimurium LPS banding patterns (figure 21) showed a shift between the bands of 
the basal strain (strain 101), containing no know O-antigen modification genes, and the Gtr III 
strain (strain 122). This showed that the expression of gtr(III) from the Ptac promoter in strain 
122 was modifying the LPS in S. Typhimurium. Between the LPS banding pattern of the Gtr 
III strain and the Gtr III+IV strain (strain 921) there was no detectable shift seen. The un-
induced Gtr III+IV, where no IPTG was added to the culture, had the same LPS banding 
pattern as the induced Gtr III+IV strain but also had additional shadow bands that were level 
with bands of the basal strain. (Figure 21) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
921$ 122$ 921$ 921$101$
Genome$
expression$ Gtr$III$ Basal$ Gtr$III$ Gtr$III$ Gtr$III$
plac22$
expression$ Gtr$IV$ 7$ 7$ Gtr$IV$ Gtr$IV$
Figure 21: LPS analysis of a strain expressing the gtr families III and IV. 
Extracted LPS ran on a TSDS-PAGE gel. The table above the lanes indicates which gtr genes 
are being expressed in that strain. The top row refers to the genes that are being expressed from 
the Ptac promoter in the genome, basal means that no gtr genes are expressed from that strain. 
The bottom row refers to the gtr genes that are being expressed from the lac promoter in the 
Plac22 plasmid, empty vector means that there are no genes expressed from the lac promoter but 
the Plac22 vector is still present. A dash indicates that there was no vector in that strain. Cells 
that are shaded green signify that that strain was induced with IPTG. The numbers below the 
lanes give the strain numbers, strain details can be found in table A2.3. The red arrows are 
pointing to shadow bands.  
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5.1.2 Can Gtr family V modifications of the S. Infantis O-antigen provide 
family IV GtrC with a target for activity? 
 
There was a shift between the LPS banding patterns of the basal strain (strain 288) and the 
strain only expressing the gtr(V) genes (strain 328) (figure 22). Therefore, family V Gtr 
proteins were modifying the O-antigen repeating unit in S. Infantis.  
When the gtr(IV) genes are expressed in a strain with gtr(V) under the Ptac promotor (strain 
928) no detectable shift was seen. Additionally, the banding pattern of strain Gtr V+Plac22 
(strain 927) had the same banding pattern as the other strains containing gtr(V) under the Ptac 
promoter. But as well as the main banding pattern there were two additional shadow bands, 
indicated with red arrows, that appeared to be running level with the basal bands. (Figure 22) 
 
 
 
 
 
 
 
 
 
 
 
928$ 288$ 328$ 928$ 927$
Genome$
expression$ Gtr$V$ Basal$ GtrV$ Gtr$V$ Gtr$V$
plac22$
expression$ Gtr$IV$ 8$ 8$ Gtr$IV$
Empty$
Plac22$
928$ 288$ 328$ 928$ 927$
Genome$
expression$ Gtr$V$ Basal$ GtrV$ Gtr$V$ Gtr$V$
plac22$
expressi n$ Gtr$IV$ 8$ 8$ Gtr$IV$
Empty$
Plac22$
Figure 22: LPS analysis of a strain expressing the gtr families Vand IV. 
Extracted LPS ran on a TSDS-PAGE gel. The table above the lanes indicates which gtr genes are 
being expressed. The top row refers to genes that are being expressed from the Ptac promoter in the 
genome, basal means that no gtr genes are expressed from that strain. The bottom row refers to the 
gtr genes that are being expressed from the lac promoter in the Plac22 plasmid, empty vector means 
there are no genes expressed from the lac promoter but the Plac22 vector is still present. A dash 
indicates that there was no vector in that strain. Cells that are shaded green signify that the strain 
was induced with IPTG. The numbers below the lanes give the strain numbers, strain details can be 
found in table 16. The red arrows are pointing to shadow bands.  
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5.1.3 Can Gtr family VI modifications of the S. Infantis O-antigen provide 
family IV GtrC with a target for activity? 
 
There was a shift between the LPS banding patterns of the basal strain (strain 288) and the 
strain only expressing the gtr(VI) genes (strain321) (figure 23). Therefore, family VI Gtr 
proteins were modifying the O-antigen repeating unit in S. Infantis.  
In figure 23 There was a clear shift between the banding pattern of strain Gtr VI (strain 321) 
and strain Gtr VI+IV (strain 930) showing that the additional presences of the Plac22 plasmid 
expressing gtr(VI) was changing the O-antigen of a strain 930 expressing gtr(VI) from the 
Ptac promoter. This banding pattern appeared to be running level with the basal strain bands.  
However, the same effect was seen when an un-induced empty Plac22 plasmid was present. 
The IPTG induced strain Gtr VI+IV had shadow bands, indicated by the red arrow, which 
was running at the same level as strain 321. (Figure 23)  
 
  
 
 
 
 
 
 
 
 
 
929# 930# 321# 288#930#
Genome#
expression# Gtr#VI# Gtr#VI# Gtr#VI# Gtr#VI# Basal#
Plac22#
expression# Empty#Plac22# Gtr#IV# Gtr#IV# <# <#
Figure 23: LPS analysis of a strain expressing the gtr families VI and IV. 
Extracted LPS ran on a TSDS-PAGE gel. The table above the lanes indicates which gtr genes 
are being expressed in that strain. The top row refers to the genes that are being expressed from 
the Ptac promoter in the genome, basal means that no gtr genes are expressed from that strain. 
The bottom row refers to the gtr genes that are being expressed from the lac promoter in the 
Plac22 plasmid, empty vector means that there are no genes expressed from the lac promoter but 
the Plac22 vector is still present. A dash indicates that there was no vector in that strain. Cells 
that are shaded green signify that that strain was induced with IPTG. The numbers below the 
lanes give the strain numbers, strain details can be found in table 16. The red arrows are 
pointing to shadow bands.  
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5.1.4 Summary of results and interim conclusion 
 
Taken together the data presented above shows that the presence of an empty Plac22 plasmid 
could cause a modification of the O-antigen of a strain expressing a gtr operon from a Ptac 
promoter in the genome. In a Gtr VI+Plac22 strain this could be seen though the whole of the 
LPS banding pattern which was running level with basal. In the un-induced Gtr V+Plac22 and 
un-induced Gtr III+IV strains the modifications caused by a Plac22 vector could be seen 
through the shadow bands that are also running at the basal level. The shadow bands show a 
proportion of extracted O-antigen that has differential modification to the rest of the extracted 
O-antigen. This was likely to be due to the LacIq repressor protein produced from the Plac22 
plasmid.  
 
The LacIq repressor protein represses the expression from the lac promoter on the Plac22 
vector providing an inducible form of expression. However the chromosomal Ptac promoter, 
which gtr(III), (V) and (VI) were being expressed from, can also be bound and repressed  by 
the LacIq repressor protein as the Ptac promoter is a combination of the trp and, importantly, 
the lac promoter (Amann et al., 1983) (figure 24). This relationship had not been taken into 
account when designing this experiment and strains containing an empty Plac22 vector were 
not induced with IPTG, which binds and inactivates the LacIq protein.  
 
 
 
 
 
 
 
 
Figure 24: 
Activity of the 
LacIq repressor. 
A diagram showing 
the promoter targets 
of the LacIq 
repressor and 
induction of the 
promoters by IPTG.  
Chromosomal)DNA))
Plac22)plasmid)
Tac)promoter)
gtr$family)III/V/VI)operon)$
gtr$family)IV)operon)$
lac)promoter) lacIq&repressor&
IPTG)
IPTG)
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Therefore, the phenotype of a strain with a gtr operon under the Ptac promoter containing an 
un-induced vector is showing a basal phenotype which could clearly be seen in strain Gtr 
VI+Plac22 and un-induced Gtr VI+IV (figure 23). Induced Gtr VI+IV has shadow bands 
running level with strain Gtr VI which could be O-antigen that has been modified by the 
Gtr(VI) proteins. However, the main banding pattern is running at the basal level suggested 
that induction may not be sufficient to stop all repression from the Ptac promotor (figure 23). 
In strains with gtr(III) (figure 21) and gtr(V) (figure 22) under the Ptac promoter the presence 
of an un-induced vector and repression of the Ptac promoter seemed to have less of an effect 
on the phenotype; only shadow bands can be seen returning back to the basal level in both 
strains. Hence, LacIq repression was not preventing all expression from the Ptac promoter.  
 
5.2 CAN INDUCTION STOP A PLAC22 VECTOR 
CAUSING MODIFICATION TO A PTAC-GTR 
STRAIN’S O-ANTIGEN? 
 
5.2.1 Modifications of the O-antigen observed in the presence of Plac22 was 
due to its effect on the Ptac promoter. 
 
To demonstrate that the effect of the Plac22 plasmid on the LPS banding pattern was due to 
repression of the Ptac promoter the banding patterns of a basal S. Typhimurium strain with 
and without the Plac22 plasmid was compared.  An experiment that swapped the empty 
Plac22 vector for a pBAD vector in the Gtr VI strain was also done to control for the effect of 
ampicillin on the LPS banding pattern of a S. Infantis strain with the family VI modification, 
as this antibiotic targets cell wall synthesis.   
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Plac22%%
Basal%+%
Plac22%Basal%% Basal%%
472% 472%614% 614%
Gtr%VI+pBAD% Gtr%VI%
321%%321%+pBAD%
A% B%
In figure 25A there was no shift seen between the S. Typhimurium basal strain and the basal 
strains containing induced or un-induced empty Plac22 vector, this showed that without 
chromosomal gtr expression from the Ptac promoter Plac22 had no effect on the banding 
pattern. No shift was seen between the Gtr VI strain with and without pBAD (figure 25B), 
which showed that ampicillin is not having an effect on the LPS banding pattern of this strain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Plac22’s effect on the O-antigen is likely due to repression of the ptac 
promoter. 
Extracted LPS ran on a TSDS-PAGE gel. The labels below the lanes indicate which strain the LPS 
was extracted from, details of these strains can be found in table 14.  A: All strains have a basal 
genotype with no known O-antigen modifying genes present.  The labels above indicate whether the 
Plac22 vector is present. Green boxes behind the text highlight strains that have been induced with 
IPTG. B: Both strains have gtr(VI) under the Ptac promoter. The labels indicate whether the pBAD 
vector is present.  
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5.2.2 Is induction of a strain containing a Plac22 vector sufficient to stop 
repression from the Ptac promoter? 
The previous experiments were repeated and every strain containing a Plac22 plasmid was 
induced with IPTG. The induced strain containing an empty Plac22 vector was compared to 
an un-induced form so that the effect of induction of the Ptac promoter could be seen.  
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plac22!
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Empty!
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Empty!
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In figure 26 There was a shift between the S. Infantis strains Gtr VI and un-induced Gtr 
VI+Plac22. In the induced form there was still a clear shift against the Gtr VI strain but there 
were shadows of bands running level with the Gtr VI strain. Similarly, the Gtr VI+IV strain 
was shifted compared to the Gtr VI strain but had shadow bands that were running at the 
same level. The main banding patterns of strains: Gtr VI+IV, Gtr VI+Plac22 induced and Gtr 
VI+Plac22 un-induced were running level with the basal strain (Figure 26). Therefore, the 
presence of a Plac22 vector in an induced or un-induced strain expressing gtr(VI) from the 
Ptac promoter caused the banding pattern to shift to the basal level. But, in the induced strains 
a small amount of the O-antigen did not shift against the Gtr IV strain creating shadow bands. 
The same experiment was done using strains with gtr(V) under the Ptac promoter. 
Unfortunately, there was an insufficient amount of LPS loaded to see the banding pattern 
(Figure not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: LPS analysis of strain expressing the gtr families VI and IV (all 
strains were induced). 
Extracted LPS ran on a TSDS-PAGE gel. The table above the lanes indicates which gtr genes are 
being expressed in that strain. The top row refers to the genes that are being expressed from the 
Ptac promoter in the genome, basal means that no gtr genes are expressed from that strain. The 
bottom row refers to the gtr genes that are being expressed from the lac promoter in the Plac22 
plasmid, empty Plac22 means that there are no genes expressed from the lac promoter but the 
Plac22 vector is still present. A dash indicates that there was no vector in that strain. Cells that are 
shaded green signify that that strain was induced with IPTG. The numbers below the lanes give the 
strain numbers, strain details can be found in table 16. The red arrows are pointing to shadow 
bands.  
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5.3 CHAPTER CONCLUSION 
 
The addition of the Plac22 plasmid to a basal S. Typhimurium strain does not alter the LPS 
banding pattern (figure 25A). Thus the shifts due to its presence, seen previously (figure 23), 
must be because of its effect on the expression of the gtr operons from the Ptac promoter. 
Although, a further control using basal S. Infantis as well as S. Typhimurium would have 
been useful.  
 
Induction with IPTG does not appear to be sufficient to stop all repression of the Ptac 
promoter. The induced Gtr VI strain containing empty Plac22 is shifted compared to the 
strain without Plac22 and is running level with the basal strain suggesting there is no 
modification of the O-antigen by the Gtr(VI) proteins (figure 26). Full modification of the O-
antigen by the Ptac-Gtr proteins is necessary to draw reliable conclusions from the result, as it 
is an essential part of this experiment. To complete these experiments a vector that has no 
effect on the Ptac promoter should be used.  
 
However, the un-induced Gtr III+IV strain in figure 21 and un-induced Gtr V+Plac22 strain 
in figure 22both show a complete banding pattern that is level with the corresponding Ptac-
Gtr strain with only two shadow bands running level with the basal strain. This shows that 
even without induction there appears to be enough expression from the Ptac promoter for the 
Gtr(V) and Gtr(III) proteins to modify the majority of O-antigen that has been extracted. Both 
Gtr III+IV (figure 21) and Gtr V+IV (figure 22)were induced with IPTG so should be 
expressing enough Ptac-Gtr proteins to sufficiently modify the O-antigen. Therefore, although 
experiments using an alternative vector would be more reliable, conclusions can be drawn 
from the results in figure 21 and 2. In S. Typhimurium and S. Infantis Gtr(III) and Gtr(V) 
modifications respectively do not provide a target for detectable modification by the Gtr(IV) 
proteins.   
 
Furthermore, if we make the assumption that the shadow bands of the induced Gtr VI+IV 
strain (figure 26) are showing a banding pattern that is being modified by the Gtr(VI) proteins 
then these results would show that the addition of the family IV proteins are not giving a 
detectable modification of the O-antigen.  
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It is interesting that the presence of the LacIq repressor had a stronger effect in the strain 
expressing gtr(VI) from the Ptac promoter. We would expect LacIq repression of the Ptac 
promoter to be the same in every strain. Therefor, the difference may have been due to 
differences between the ways each family of Gtr proteins works. For example, the Gtr(VI) 
proteins may need to be present in higher quantities to efficiently modify the O-antigen than 
Gtr(III) and (V), meaning that a drop in expression from the Ptac promoter can only be seen 
in the Gtr VI strain’s phenotype. 
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6. IS THE FUNCTION OF THE FAMILY IV GTRAB 
PROTEINS DISTINCT FROM OTHER 
FAMILIES GTRAB PROTEINS? 
 
 
A phylogenetic analysis, of the Gtr proteins in S. enteriaca, S. bongori and 4 phage genomes, 
done by Davies et al., 2013 used the GtrC protein to split the Gtr proteins in to ten families 
based on the clustering of the GtrC proteins. The analysis showed that family IV GtrA 
clustered into the same group and family IV GtrB clustered into the same group. Theses 
groups don’t contain GtrB or GtrA proteins from another family. Unlike Family IV the other 
families (excluding family II which is an acetyltransferase (Kintz et al., 2015)) GtrA and GtrB 
proteins were split across different clusters showing that there has been recombination 
between operons. In the family IV operons this recombination hasn’t happened. A reason for 
this may be that family IV GtrAB cannot replace the function of other GtrAB proteins.  As 
well as this difference, alignments of GtrA and GtrB (figure X-don’t have a figure number 
yet) highlighted that the family IV GtrA and GtrB proteins had the most AA changes from the 
consensus sequence.   
 
These observations pointed to the hypothesis that family IV AB proteins were functionally 
different from other families’ GtrAB proteins. This hypothesis was tested by replacing 
GtrAB(I) with GtrAB(IV) to see if the family IV GtrAB proteins could work with GtrC(I) and 
replace the function of GtrAB(I). If the family IV proteins had a function that is distinct from 
the other Gtr proteins then the replacement would lead to a non-functional gtr operon and a 
basal LPS phenotype. To do this a strain was used that had gtrAB(IV) expressed from the 
Ptac promoter in the genome and gtrC(I) expressed from the lac promoter on the Plac22 
plasmid.  
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6.1 GENERATION OF STRAIN EXPRESSING THE 
FAMILY I AND FAMILY IV GENES 
 
A strain was generated that expressed gtrAB(IV) in place of gtrAB(I) (Table 4). To do this 
strain 141 was used, which expressed gtrAB(IV) (gtrC(IV) had been removed from the 
operon) from the Ptac promoter but had no other known O-antigen modifying genes. Strain 
141 was then transformed with plasmid 461, which is a plac22 vector that has gtrC(I) under 
the lac promoter. This generated strain 970, which expressed gtrAB(IV) from the Ptac 
promoter and gtrC(I) from the lac promoter on the Plac22 plasmid, but no other known O-
antigen modifying genes were expressed. Stain 970 will be referred to as GtrAB(IV)C(I).  
 
Four control strains were also generated (Table 4). Two of these strains were 967 and 968. 
Strain 967 expressed only gtrABC(I) and was made by transforming a basal strain (strain 
101), with no known O-antigen modifying genes, with plasmid 460. Plasmid 460 was a 
plac22 vector with gtrABC(I) under the lac promoter. Strain 968 expressed only gtrC(I) and 
was made by transforming a basal strain with plasmid 461, which was a plac22 vector with 
gtrC(I) under the lac promoter. The two other control stains were 969 and 966.  Strain 969’s 
parent strain was strain 141, which has gtrAB(IV) under the Ptac promoter. Strain 966’s 
parent strain was strain 101, which is a basal strain that expresses no known O-antigen 
modifying genes. Both strains were made by transformation with an empty plac22 vector, 
which had no genes under the lac promoter. These two strains were generated to control for 
the effect of the plac22 vector on the O-antigen.  
Table 4: Table of strains used in chapter 6 experiments 
Strain	
Genes	expressed	from	
chromosomal	Ptac	
promoter	
Genes	expression	
from	Plac22	Vector		
970/GtrAB(IV)C(I)	 gtrAB(IV)	 gtrC(I)	
967/GtrABC(I)		 -	 gtrABC(I)	
968/GtrC(I)		 -	 gtrC(I)	
966	 -	 Empty	vector	
969	 gtrAB(IV)	 Empty	vector	
*All	strains	contain	no	other	gtr	genes	except	for	those	specified	
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Figure 27: Removal 
of the lacIq  gene 
from Plac22. 
A	diagram	illustrating	the	
method	of	removal	of	the	
lacIq	gene	from	the	
Plac22	plasmid.	The	blue	
plasmid	is	the	complete	
Plac22	plasmid	with	lacIq	
and	the	red	plasmid	is	the	
lacIq	free	plasmid	after	
modifications.	The	red	
arrows	are	showing	the	
forward	and	reverse	
primers,	which	are	oMV	
1254	and	oMV	1255	
(table	14).		
The plac22 vector is an inducible expression system because the vector holds the lacIq gene; 
whose product will repress the lac promoter. Induction happens when IPTG is added to the 
culture and will bind the LacIq protein and stop it from binding the lac promoter. The LacIq 
repressor can also bind and repress the Ptac promoter, which was used in combination with 
the plac22 vector in this experiment. In previous experiments in chapter 5, induction with 
IPTG was not always sufficient to stop all repression by the LacIq protein. Therefore, before 
each strain was transformed with Plac22 the vector was modified by cutting out the lacIq 
gene to stop repression of both the lac promoter on the vector and the Ptac promoter in the 
genome. 
 
Modification of the Plac22 vector was done by high fidelity PCR amplification (for methods 
see section 2.3.) of the whole Plac22 vector excluding the lacIq gene using primers oMV 
1254 and oMV 1255 (table 14). The linear product was then digested (see section 2.5.) and 
ligated (see section 2.6.) together to create a lacIq free Plac22 vector that was used in all parts 
of this experiment (Figure 27). The vectors that were created were plasmids 461, 460 and 
459. 
 
 
 
 
 
 
 
 
 
 
To show that the lacIq gene was successfully deleted from plasmids 461, 460 and 459 they 
were digested with restriction enzymes Bg1II and pstI generating two linear fragments of 
DNA. One of the fragments contained the site that the lacIq gene was deleted from. The 
plasmid digest was run on an agarose gel to separate out the two fragments and calculate their 
PCR$
ampliﬁca,on$
Digest$
&$
ligate$$
Plac22$
Plac22$
6$lacIq$
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Plasmid	
459	 M	
Plasmid	
461	M	
Plasmid	
460	 M	
1000	bp	
1200	bp	
3000	bp	
4000	bp	
6000	bp	
8000	bp	
lengths. All three plasmids would have had a DNA fragment length of 1141bp if the lacIq 
gene had been deleted or 2033pb if the lacIq gene was still present.  The second larger 
fragment lengths of plasmids 459, 460 and 461 were approximately 3619bp, 6346bp and 
4843bp respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The gel in figure 28 shows that all three of the digested plasmids have one fragment length 
that is slightly below the 1200bp level of the marker indicating this is the 1141bp fragment 
and therefore the lacIq gene has been removed. The larger fragments for each plasmid are 
around the lengths 3619bp, 6346bp and 4843bp for plasmids 459, 460 and 461 respectively. 
 
Figure 28: The lacIq gene was successfully deleted from plasmids 461, 
460, and 459. 
Agarose	gel	electrophoresis	of	plasmids:	461,	460,	and	459	digested	with	restriction	
enzymes	Bg1II	and	PstI.	The	length	of	the	smaller	fragment	for	all	plasmids	was	
1141bp.	This	was	the	region	that	contained	the	lacIq	gene.	With	the	lacIq	gene	the	
fragment	length	would	be	2033bp	long.	The	second	larger	fragment	lengths	of	
plasmids	459,	460	and	461	were	approximately	3619bp,	6346bp	and	4843bp	
respectively.	Above	the	lanes	are	labels	giving	the	plasmid	numbers	and	indicating	
the	marker	lanes	(M).	The	marker	used	was	GeneRuler	DNA	Ladder	mix	from	Thermo	
Scientific.		
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To demonstrate that the LacIq protein was no longer present in the strain and could not 
repress the promoters a comparison of the LPS banding patterns of induced and un-induced 
strain 967, expressing gtrABC(I) from the lac promoter was done. If the LacIq protein were 
present, then it would be repressing the lac promoter in a strain that had not been induced 
with IPTG, preventing gtrABC(I) expression. This would mean that the O-antigen would not 
be modified and the strains O-antigen banding pattern would be running at a different level to 
a strain that had been induced and was expressing the gtrABC(I) genes. However, if the LacIq 
protein is not present then the O-antigen banding pattern of an induced and un-induced strain 
967 would be the same. A basal strain 966 expressing no gtr genes and containing an empty 
plac22 vector was used as a control to show that the family I Gtr proteins were modifying the 
O-antigen.  
 
When comparing the induced and un-induced strains’ banding patterns in figure 29 there was 
no shift between the induced and un-induced forms. If LacIq were still active a difference in 
the banding patterns of the induced and un-induced forms of strain 967 would have been seen. 
There was a shift between the O-antigen banding patterns of the 967 strain and the basal 966 
strain which showed that in both the 967 samples the O-antigen had been modified by 
GtrABC(I). 
 
 
 
 
 
 
 
 
 
 
 
Figure 29: LPS analysis of 
induced and un-induced strain 
967. 
Extracted LPS ran on a TSDS-
PAGEgel. The table above the lanes 
indicates which gtr genes are being 
expressed in the strain. The top row 
gives the chromosomal gtr expression: 
basal means that no gtr genes are 
expressed from the chromosome of 
that strain. The bottom row gives the 
plac22 vector gtr expression: 
gtrABC(I) is being expressed from the 
lac prompter on the plac22 vector. 
empty vector means that there are no 
genes expressed from the lac promoter 
but the Plac22 vector is still present. 
The labels above the lanes indicate if 
the strain was induced (In) or un-
induced (Un). 
	
Genome	
expression Basal Basal
Plac22	
expression GtrABC(I)
Empty	
vector
966
In Un In
967
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6.2 CAN GTRAB(IV) WORK WITH GTRC(I) TO MODIFY 
THE O-ANTIGEN? 
 
To study whether the function of GtrAB(IV) was distinct from other families’ GtrAB 
proteins, the expression of gtrAB(I), from the family I operon, was replaced by expression of 
gtrAB(IV) making strain 970 as described above. The O-antigen of this strain was studied to 
see if it had modifications compared to a basal strain’s O-antigen. If modification of the O-
antigen was possible with this combination of genes then the function of GtrAB(IV) would be 
similar to that of GtrC(I).  
 
To do this LPS was analysed from S. Typhimurium strains: 970 expressing gtrAB(IV) from 
the Ptac promoter in the genome and gtrC(I) from the lac promoter on the Plac22 vector, 967 
expressing only gtrABC(I) from the lac promoter on the Plac22 vector, 968 expressing only 
gtrC(I) from the lac promoter on the Plac22 vector, 966, which is a basal strain and is 
transformed with an empty plac22 vector and 969 expressing gtrAB(IV) from the Ptac 
promoter in the genome and has been transformed with an empty Plac22 vector. Strains 970, 
968 and 967 will be refered to as: GtrAB(IV)C(I), GtrC(I) and GtrABC(I) respectively. 
Details of all strains used can be found in table 16. 
 
LPS was extracted from the strains and ran on a TSDS-PAGE gel (for methods see section 
2.9.) that separated out varying lengths of O-antigen repeating units creating a laddered 
banding pattern. A shift between two strains banding pattern indicated that a sugar molecule 
had been added to the O-antigen repeating unit in one of the strains.  
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Genome	
expression	 Basal	 Basal	 Basal	 GtrAB(IV)	 Basal	 Basal	 GtrAB(IV)	GtrAB(IV)	
plac22	
expression	 GtrABC(I)	
Empty	
Vector	 GtrC(I)	 GtrC(I)	 GtrABC(I)	 GtrC(I)	 GtrC(I)	
Empty	
Vector	
Strain	 967	 966	 968	 970	 967l	 968	 970	 969	
Lane		 1	 2	 3	 4	 5	 6	 7	 8	
Genome	
expression	 Basal	 Basal	 Basal	 GtrAB(IV)	 Basal	 Basal	 GtrAB(IV)	GtrAB(IV)	
plac22	
expression	 GtrABC(I)	
Empty	
Vector	 GtrC(I)	 GtrC(I)	 GtrABC(I)	 GtrC(I)	 GtrC(I)	
Empty	
Vector	
Strain	 967	 966	 968	 970	 967l	 968	 970	 969	
Lane		 1	 2	 3	 4	 5	 6	 7	 8	
From comparing the LPS banding patterns of the strains in figure 30 there was a shift seen 
between strains GtrC(I) (strain 968) and GtrABC(I) (strain 967). Strain GtrC(I) was running 
level with the Basal+Plac22 strain (strain 966) whereas the GtrABC(I) banding pattern had 
shifted  above the basal level banding pattern showing that the GtrC(I) strain had no 
modifications to its O-antigen whereas the strain expressing the full family I operon was able 
to modify the basal O-antigen. Importantly there was a shift between the strain 
GtrAB(IV)C(I) (strain 970) and GtrC(I). Also the GtrAB(IV)C(I) strain was running at the 
same level as GtrABC(I) so had modifications to its O-antigen repeating unit.  
There was a shift between the banding patterns of strain 970 and 969, both expressing 
gtrAB(IV) from the genome, the only difference between these two strains was the expression 
of gtrC(I) fro  the lac promoter in strain 970 whereas strain 969 had an empty Plac22 
plasmid. This demonstrates that it was the presence of GtrC(I) that caused a shift, not Plac22
Figure 30: LPS analysis of a strain expressing gtrAB(IV) and gtrC(I). 
Extracted	LPS	ran	on	a	TSDS-PAGE	gel.	The	tables	above	the	lanes	indicate	which	gtr	genes	are	being	
expressed	in	that	strain.	The	top	row	refers	to	the	genes	that	are	being	expressed	from	the	Ptac	
promoter	in	the	genome,	basal	means	that	no	gtr	genes	are	expressed	from	the	chromosome	of	that	
strain.	The	bottom	row	refers	to	the	gtr	genes	that	are	being	expressed	from	the	lac	promoter	in	the	
Plac22	plasmid,	empty	vector	means	that	there	are	no	genes	expressed	from	the	lac	promoter.		The	
table	below	the	lanes	indicate,	on	the	top	row,	which	strain	number	the	LPS	was	extracted	from,	
details	of	these	strains	can	be	found	in	table	16.	The	bottom	row	of	the	table	gives	the	lane	numbers.	
All	strains	were	induced	with	IPTG.		
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6.3 CHAPTER CONCLUSION 
 
The results in figure 29 have shown that the modification of the Plac22 plasmid successfully 
prevented the production of an active LacIq protein as there was no difference between an 
induced and un-induced strain 967 expressing gtrABC(I) from the lac promoter. Furthermore, In 
figure 30 the comparison between strain 970 and 969 demonstrated that gtrC(I) and gtrAB(IV) 
were being fully expressed as the modification of strain 970 must have been due to the 
additional expression of gtrC(I) and as gtrC(I) can’t, by its self, modify the O-antigen then 
gtrAB(IV) must also have sufficient expression in this strain. 
 
In figure 30 GtrC(I) (lane 3) and Basal+Plac22 (lane 4) strains were running equal with each 
other but shifted against the GtrABC(I) strain (lane 1) showing that the presence of the GtrC(I) 
protein by its self was not enough to modify the O-antigen and therefore had a basal O-antigen. 
This result was expected, as GtrC cannot modify the O-antigen without the assistance of GtrAB. 
But when the expression of gtrAB(IV) was introduced the O-antigen was modified and the 
strains LPS banding pattern ran level with that of a GtrABC(I) strain. This showed that the 
family IV GtrAB proteins could work with GtrC(I) and replace the function of GtrAB(I). This 
goes against the idea that the family IV GtrAB proteins have a function distinct from most other 
families and proves that their activities must be functionally the same.  The function of a GtrC 
protein is specific to each family (Allison and Verma, 2000) and as family I proteins 
collectively mediate the addition of glucose onto the basal repeating unit the GtrAB(IV) 
proteins, in place of GtrAB(I), must have also bound a glucose and passed it to GtrC(I).  
 
To improve the design of this experiment a strain that expressed gtrAB(I) from the Ptac 
promoter in the genome and gtrC(I) from the lac promoter on the Plac22 plasmid would have 
been a more reliable control. This control could replace strain 967 which expressed gtrABC(I) 
from the lac promoter on Plac22. This improvement would mean that when comparing it to 
strain 970 both gtrAB(I) and gtrAB(IV) would be expressed from the same place. This would 
control for any differences in expression from the two promoters. Also, it would control for any 
difference that came from gtrAB and gtrC being transcribed separately as apposed to in an 
operon. However, this control would have mainly been necessary if the results showed that 
strain 970 were not able to modify the O-antigen.  
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If the GtrAB(IV) can work with the GtrC(I) proteins then why has there not been any 
recombination of the family IV operon with other family proteins? It could be that the family IV 
gtr operon is evolutionarily younger than the other gtr families and there has not been as much 
time for the operon to recombine. Or the potential TSS within gtrB may have prevented any 
recombined operons from persisting within a population because gtrC(IV) needs to be down 
stream of gtrB(IV) to have the correct transcriptional control relevant to its role in infection. 
The differences observed in the family IV GtrAB AA sequence could reflect that the family IV 
operon is more evolutionarily distant from the other families.  
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7. DISCUSSION 
 
 
7.1 EXPRESSION OF THE FAMILY IV GTR GENES 
 
The results of chapter 4 did not identify and conditions that induce up regulation of the family 
IV gtr genes. However, the results provided other information about the expression of the gtr 
genes from the main operon promoter and a possible promoter within gtrB 
 
7.1.1 Expression from the main operon promoter upstream of gtrA 
 
The results in chapter 4 suggest that under certain conditions the family IV operon promoter 
shows variable levels of expression. It could be the case that this operon phase varies under 
certain conditions. Changes to switch frequency of phase variable genes due to changes in 
environmental stimuli has been observed in E. coli where temperature and growth media can 
modulate the on to off switch frequency of the type 1 fimbriae genes (Gally et al., 1993).  
 
However, phase variation was not observed when the family IV operon promoter region was 
put in front of the lacZ gene in this study and others(Broadbent et al., 2010). But it may be the 
case that a larger up stream region is needed for phase variation that was not included in the 
lacZ constructs. Or, phase variation of the lacZ construct was not seen because the switch 
frequency is too quick for a difference between two colonies expression of the lacZ gene to be 
appreciated through the colour of the colony. The family IV operon can not phase vary in the 
same way as many other gtr families can; through a OxyR and Dam dependent mechanism. The 
upstream region of the family IV operon has no GATC sites, which are methylation sites need 
for phase variable expression through the Dam and OxyR mechanism. Other DNA motifs 
associated with phase variation have not been identified either; no tandem repeats were found 
within the sequence upstream of the gtrA start codon using a tandem repeat finder (Benson, 
1999). Tandem repeats are associated with slipped-strand mispairing; short repeating DNA 
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sequences cause mispairing of strands during DNA replication altering the number of repeats 
which can effect transcription if the repeats are in a promoter region or translation if the repeats 
are after the transcriptional start site (Torres-Cruz and van der Woude, 2003) (van der Woude, 
2011). 
 
But there are other methods of phase variation that have been observed in bacteria that could 
possibly be the case for the family IV genes. The family IV genes could be under the control of 
a transcriptional promoter or suppressor that has a phase variable expression. An example of 
this method of phase variation is the filC gene encoding the flagellin protein. Its expression is 
repressed by the FljA protein, which is produced from a phase variable promoter controlled by a 
DNA inversion mechanism. The FljA protein also represses translation of the protein by 
binding to the 5’-untranslated region and consequently promotes degradation of the transcript 
(Bonifield and Hughes, 2003) (Yamamoto and Kutsukake, 2006).  This method of phase 
variable control would not be detectable using a beta-galactosidase assay. Other mechanisms of 
phase variation that don’t involve the phase variation from the gene’s promoter have been 
observed. The cmpV gene in E. coli is controlled by a DNA inversion mechanism which is 
down stream of the promoter region. It is predicted that in the off state the transcript, containing 
the switch region, forms a stable stem loop followed by a poly U tract, which causes 
transcription to be terminated (Emerson et al., 2009).  
 
7.1.2 Expression from a possible promoter within gtrB 
 
As well as the main operon promoter it was predicted that gtrC could be expressed 
independently from TSS within gtrB based on RNA-seq data of S. Typhimurium primary 
transcripts (personal correspondence with Disa Hammerlof). Expression from a region within 
gtrB was measured and showed a 7-fold increase in expression compared to a control (section 
4.3.). Possible promoter regions were also found upstream of the gtrC start codon. These results 
indicate that the gtrC(IV) can be expressed by its self independently of the main promoter. This 
is supported by the results seen in section 4.1.2., which suggested that the two genes were being 
expressed independently of each other and responding differently to environmental ques. 
 
Independent and differential expression of gtrC from the main operon promoter suggests that 
gtrC may have a function independent of gtrAB under certain conditions. This is supported by 
the findings of Chaudhuri et al.,  who reported that gtrABC were needed for persistence within 
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chickens, pigs and cattle but only gtrC was needed for persistence within a mouse (Chaudhuri et 
al., 2013). This implies that GtrC does not need GtrAB for persistence within a mouse.  GtrC 
could have a secondary function that does not require GtrAB, for example it could be 
functioning with other proteins that transfer a different sugar or are localized to a different part 
of the membrane.  
 
The RNA-seq data produced by Kröger et al., (Kröger et al., 2013) also showed that the family 
IV genes had different transcript levels under different conditions. Consistent with the results in 
section 4.1.2. the RNA-seq data showed that gtrC had a higher up regulation than gtrA under 
pH3 conditions compared to the control. Also, when comparing expression from the region 
within gtrB with the gtrA upstream region, there appears to be more expression from the 
promoter within gtrB than the main operon promoter (sections 4.2.1. and 4.3.). However it 
would be useful to repeat these assays in parallel so that all conditions can be kept constant. In 
contrast to this, the RNA-seq data shows that over all the transcript level, measured in 
transcripts per million, is highest in gtrA and lowest in gtrB, with gtrC in the middle. These 
differences could be due to a combination of post-transcriptional controls and differential 
expression of the genes through different promoters.  
 
7.2 WHAT SUGAR ARE THE FAMILY IV GTR PROTEINS 
BINDING? 
 
To date only the function of four out of ten of the gtr families has been elucidated. Both 
families I and III mediate the addition of a glucose onto the O-antigen repeating unit of S. 
Typhimurium. The phylogenetic tree generated from the alignments of all family GtrC proteins 
in section 3.5.3. showed that the family I, III and IV clustered into a group showing that family 
IV GtrC had a higher sequence similarity with the family I and III GtrC proteins than with the 
other Gtr families. The phylogenetic tree further showed that there was a higher sequence 
similarity between GtrC proteins from family III and IV than between family III and I. An 
alignment of just the family I, III and IV GtrC proteins showed that the N-terminal region was 
more conserved between all proteins with the long periplasmic C-terminal tail having less 
sequence similarity. As both family I and III proteins mediate the addition of a glucose then we 
would expect there to be a conserved region binding the glucose sugar. There is a region 
between the first two trans-membrane domains, in the periplasm, that is the only non trans-
membrane domain with a cluster of conserved AA. As these AA are conserved in both the 
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family I and III proteins they may be involved in binding the glucose molecule. To strengthen 
this theory, glycosyl transferase proteins that are known to bind a glucose molecule, including 
the family I and III proteins, were aligned. This alignment had just one clustering of conserved 
AA, which is likely to be the AA involved in binding the glucose molecule as this is the 
functional commonality between these proteins. This clustering of conserved AA was at the 
same position as the one found in the alignment of the family I, III and IV GtrC proteins. 
Although, in family IV one of the conserved AA was not present but the other three: 
tryptophan, glycine and aspartic acid were conserved. The presence of three conserved AA that 
appear to be needed for glucose binding could indicate that GtrC(IV) is binding a glucose sugar. 
The conclusions of chapter 6 also support this.  
 
The results in chapter 6 suggest that GtrAB(IV) bound a glucose molecule. They were able to 
replace the function of GtrAB(I) despite both GtrAB(IV) being the most distant in terms of AA 
sequence compared to the other families studied.  
 
Although it is possible that GtrAB(IV) are not specific in the sugar they bind and the result in 
chapter 6 does not show that GtrC(IV) binds a glucose, this result combined with the 
bioinformatics analysis strongly suggests that the GtrABC(IV) collectively bind and transfer a 
glucose molecule.  
 
7.3 IS THE O-ANTIGEN THE TARGET OF THE FAMILY IV 
GTR PROTEINS?  
 
It was predicted that the family IV GtrABC proteins function to modify the O-antigen repeating 
unit of the LPS based on their similarity with other families of Gtr proteins know to modify the 
O-antigen by glycosylation. Also, the bioinformatics analysis of GtrC(IV) (section 3.5.3.) 
showed that its AA sequence was very similar to the GtrC proteins of family I and III. The 
sequence similarity between GtrC(IV) and GtrC(III) was higher than the similarity between 
GtrC(III) and GtrC(I), which appeared to be due to clusters of AA in the C-terminal tails of 
GtrC(III) and GtrC(IV) which were not present in GtrC(I). The C-terminal tail is predicted to 
determine the specific modification and bind the O-antigen at a specific position due to a lower 
sequence similarity in this area between the family I and III proteins. Both are known to add a 
glucose molecule on to a galactose moiety but at different positions; family I makes a 1-6 
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linkage whereas family III makes a 1-4 linkage. Therefore, the clusters of similar sequences in 
the C-terminal tails shared only by GtrC(III) and GtrC(IV) could indicate that the family IV 
proteins also mediate the addition of a sugar molecule through a 1-4 linkage to a galactose 
moiety.   
 
However, when a cell constitutively expressing the family IV genes is analysed by running its 
LPS on a gel against basal LPS (extracted from a cell with no known O-antigen modifying 
genes) there is no difference between the banding patterns of each LPS extract. If the O-antigen 
were being modified we would expect to see a shift between the two banding patters. There 
could be many possible reasons for this result; the following sections will explore the arguments 
for and against each possibility. 
 
7.3.1 The gtr transcript is not being translated into protein.  
 
One of the reasons for not seeing a shift may be because the family IV gene’s constitutively 
expressed mRNA was not being translated into protein due to post-transcriptional controls 
under normal laboratory growth conditions. If the proteins function is important for growth and 
persistence during infection, then they may not be needed when grown under normal laboratory 
conditions. For example, the activity and production of the proteins may be energetically costly 
for the cell so their translation is restricted to times when they are need for persistence within a 
host.  
 
However, the results in section 6.2., which showed that GtrAB(IV) could work with GtrC(I) to 
modify the O-antigen, also showed that gtrAB(IV) must have been transcribed and translated 
into protein. In both this experiment and the Davies et al., experiments the same laboratory 
conditions were used and the genes were being expressed from the same constitutive promoter. 
Therefore, in the Davies et al., experiment gtrAB(IV) will have been transcribed into protein. 
 
However, this still does not rule out the possibility that the gtrC(IV) transcript was not being 
translated into protein as the experiments in section 6.2 only studied GtrAB(IV) activity. The 
results in section 6.2. showed that GtrAB(IV) can work with GtrC(I). GtrAB(IV) might also be 
able to work with GtrC of family III, which are also present in the S. Typhimurium genome 
along with the family IV genes, as both family I and III modify the O-antigen by addition of a 
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glucose. So translation of GtrAB(IV) could still be favorable for the cell even if GtrC(IV) is not 
under normal laboratory growth conditions.  The argument for the possibility that the gtrC and 
gtrAB transcripts have different post-transcriptional controls is supported by the observation 
that the promoter within gtrB seems to have different transcriptional controls to the main operon 
promoter discussed above.  
 
7.3.2 Are other modifications to the O-antigen are needed to provide the 
GtrC(IV) with a target for activity?  
 
One of the reasons a shift from the basal banding pattern was not seen could have been because 
GtrC(IV)’s target includes a modification of the core repeating unit of the O-antigen. The O-
antigen core repeating units of each serovar containing a family IV operon do not have a 
common sugar moiety. If GtrC(IV) is specifically targeting the O-antigen, then further 
modifications are almost certainly needed on at least one of the serovar’s O-antigens. All but 
the Cubana serovar have a mannose moiety in their core O-antigen and all but the O:7 group of 
serovars have a galactose moiety as part of their core O-antigen. The bioinformatical analysis 
done in section 3.5.3 identified the galactose moiety as a possible target of GtrC(IV) based on 
the proteins similarity with GtrC(III). While the Cubana serovar has no other gtr operons in its 
genome, the O:7 group of family IV serovars all contain the family V and VI operons as well as 
the family IV genes. The family V and VI Gtr proteins are known to modify the O-antigen 
(Davies et al., 2013) but the specific modification each family makes is unknown. Therefore, it 
is possible that the O-antigen of all family IV, O:7 group serovar’s core is being modified by 
either the family V or VI Gtr proteins by addition of a galactose sugar. This would provide a 
common sugar amongst all know O-antigen cores of family IV serovars. However, this does not 
explain why there was no shift seen when S. Typhimurium expressed the family IV genes. The 
S. Typhimurium serovar used in the experiment carried out by Davies et al. has an O:4 group O-
antigen that has a galactose sugar as part of the core O-antigen.  
 
Chapter 5 looked at whether any of the other gtr genes that share a genome with the family IV 
gtr genes were providing a modification to the O-antigen need for GtrC(IV) activity. The results 
did not show that the family III proteins in S. Typhimurium or the family V proteins in S. 
Infantis provided GtrC(IV) with a target for activity. The results of the experiment that looked 
at the family VI modification indicated that it did not provide a target for GtrC(IV) activity but 
the result was not conclusive and needed to be repeated.  
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If neither family V or VI are adding a galactose moiety to the basal O-antigen, then there may 
be other proteins present within the O:7 serovars that mediate the addition of a galactose. Or, a 
galactose moiety is not needed and another sugar is the common target of GtrC(IV). 
 
As well as the Gtr proteins there are other proteins that can modify the LPS. Bacteriophage 
often carry bacterial virulence factors, many of these target the LPS (Bondy-Denomy and 
Davidson, 2014). For example the epsilon 15 phage modifies the core O-antigen of group 
O:3,10 by changing the alpha-galactose to a beta-galactose (Losick and Robbins, 1967), which 
allows the GtrC protein of epsilon 34 to glucosylate the beta-galactose at carbon four(Kropinski 
et al., 2007; Weinbaum et al., 2013). This demonstrates that for some O-antigen modifying 
proteins the anomeric form of the sugar is a determinant of specificity. This could be the case 
for the family IV proteins. Furthermore, the galactose moiety of the S. Typhimurium O-antigen 
has been reported to have both an alpha and a beta anomeric configuration (Bogomolnaya et al., 
2008; Huang et al., 2012; Liu et al., 2014b; Reeves, 1993). This suggests that this is a 
modification that is made to the S. Typhimurium O-antigen. If the GtrC(IV) is targeting the 
galactose at carbon 4, as was suggested earlier, and is specific to one anomeric configuration, 
then this could be the reason why modification of the S. Typhimurium O-antigen was not seen 
by Davies et al., as the galactose may have been in the wrong anomeric configuration. The 
majority of the galactose containing family IV O-antigen structures are reported to have a 
galactose in the alpha configuration (section 3.2.). This could mean that the family IV proteins 
target an alpha-galactose rather than a beta-galactose if galactose is their target.  
 
The bioinformatics analysis suggested that GtrC(IV) might have a very similar function and 
even make the same linkage as GtrC(III). However, the results of Davies et al., suggest that this 
isn’t the case because GtrABC(III) can mediate a detectable modification of the O-antigen 
while GtrABC(IV) can not. But if GtrC(III) was either targeting an opposite anomeric 
configuration to Gtr(IV) or was not specific for anomeric configuration then it would be 
possible that the two proteins could have an almost identical function but GtrC(III) would be 
able to modify the S. Typhimurium O-antigen whilst the target of Gtr(IV) is not present. 
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7.3.3 The modification mediated by the family IV Gtr proteins does not give a 
detectable shift. 
 
An alternative reason for why a strain constitutively expressing the Gtr(IV) proteins did not 
have a detectable change in its O-antigen compared to a basal strain could have been because 
the modification mediated by the family IV proteins doesn’t change the size of the O-antigen 
repeating units enough to cause a visible shift to the O-antigen banding pattern.  
 
This could be because the sugar molecule added to the O-antigen is very small. For example, 
some of the smallest monosaccharaides are d- and l-glyceraldehydes and dihydroxyacetones, 
which consist of only three carbons as opposed to six carbons that make up a glucose molecule 
(Berg et al., 2002). The results of chapter 6 showed that GtrAB(IV) could bind a glucose and 
the bioinformatics analysis supported the idea that the family IV Gtr proteins bind and transfer a 
glucose. If this is the case then a shift should be seen similar to the addition of a glucose 
molecule by Gtr(I) and Gtr(III), where there is a clear shift in the O-antigen banding pattern 
compared to a basal O-antigen. However, the family IV proteins might be modifying a smaller 
number of repeating units. For example, GtrC(IV) might have a lower activity to the other Gtr 
proteins of known function. This would mean that the modification would only be increasing 
the size of the O-antigen by a small proportion and might not visibly alter the position of the 
band in the gel compared the basal O-antigen of the same length. 
 
Another type of modification that would not cause a shift would be one that added a sugar to the 
O-antigen which is replacing the position of a sugar that is part of the basal O-antigen. For 
example, the protein produced by the Salmonella phage epsilon 15, replaces the function of a 
host cell O-polysaccharide alpha polymerizing enzyme with a beta polymerizing enzyme.  This 
changes the galactose moiety from alpha to beta (Kropinski et al., 2007). As this phage protein 
is replacing the function of a host protein it does not require any GtrAB like proteins to 
function. But GtrAB(IV) have been maintained within multiple Salmonella serovar genomes as 
functional proteins, which has been demonstrated in chapter 6, suggesting that they have a 
functional role in a cell. However, GtrC(IV) could still have the same purpose as the epsilon 15 
protein but function differently and still require GtrAB(IV) to transfer a sugar molecule. 
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7.3.4 The O-antigen is not the target of family IV GtrC(IV) 
  
The reason there is no detectable modification made to the basal O-antigen when GtrABC(IV) 
is constitutively expressed could be because the O-antigen is not the target of GtrC(IV). This is 
supported by the observation that there is no common sugar between the family IV core O-
antigen structures and there is a wider diversity of O-antigen groups occupied by the family IV 
genes compared to the other gtr families. This diversity could indicate that the family IV genes 
are not restricted by the O-antigen structure of a strain because the O-antigen is not the target of 
GtrC(IV). If this is the case we would expect the GtrC(IV) target to be at the surface of the cell 
as GtrABC(IV) are all membrane proteins. We would also expect the target to be a 
polysaccharide because GtrC(IV) has a similar sequence to proteins known to target O-antigen 
polysaccharide units of the LPS.  
 
The bacterial biofilm is an important feature of bacterial persistence within the environment and 
a host and contains various polysaccharide structures: cellulose, colanic acid, and the O-antigen 
capsule (Gibson et al., 2006) (Steenackers et al., 2012). Cellulose and colanic acid have been 
found to be important components when forming a biofilm on chicken epithelial cells 
(Ledeboer and Jones, 2005), one of the hosts used in the Chaudhuri et al., study (Chaudhuri et 
al., 2013), which identified gtrABC(IV) as important genes during host persistence. In 
Salmonella Enteritidis strains the O-antigen capsule has been associated with persistence within 
the environment and resistance to desiccation (Gibson et al., 2006). In contrast, the O-antigen 
capsule of S. Typhimurium has been shown to confer resistance to killing by human serum 
(Marshall and Gunn, 2015).  
 
Whilst cellulose consists of only glucose molecules, both colanic acid and the O-antigen 
capsule of S. Typhimurium contain galactose, (Danese et al., 2000) which, after bioinformatical 
analysis, may be the target of GtrC(IV). As well as containing galactose, the O-antigen 
capsule’s trisaccharide backbone and the core LPS O-antigen share the same repeating unit in S. 
Typhimurium (Marshall and Gunn, 2015). If the O-antigen capsule is the target of GtrC(IV) 
then it makes sense that the sequence of GtrC(IV) and GtrC(III) are conserved if there targets 
are structurally very similar. Also, if GtrC(IV) is making the same modification as GtrC(III), 
which has been suggested above, it seems unlikely that they would both be maintained within 
the same serovar. But this problem can be explained if one protein is targeting the O-antigen 
and the other the O-antigen capsule.  
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If the O-antigen capsule was the target of GtrC(IV) we would expect them to have a similar 
expression pattern. The recent study by Marshall and Gunn (Marshall and Gunn, 2015) reported 
that the O-antigen capsule of S. Typhimurium appeared to have a heterogeneouse expression 
amoungst a population of cells. The results of chapter 4 sugested that gtrA could phase vary, but 
no evidence of phase variation can be seen in the promoter regoin. This could be because its 
expression is being controlled alongside the O-antigen capsule genes through a phase variable 
promoter or suppressor.  
 
7.4 FINAL CONCLUSIONS AND FUTURE EXPERIMENTS 
 
The bioinformatics analysis of GtrC(IV) and results in section 6.3. strongly suggest that the 
sugar transferred by the GtrABC(IV) is a glucose molecule and is likely to be transferring it 
onto a galactose moiety at a 1-4 position. The analysis of the serovars containing the family IV 
gtr genes showed that all but the O:7 group of serovars contained a galactose as part of their 
core O-antigen. Also, there was no common sugar between all the family IV O-antigen core 
structures. This means that if GtrC(IV) has a specific target then either there are further 
modifications needed to the core O-antigen or the O-antigen is not the target. 
 
If the O-antigen of the LPS is not the target, then it is likely that GtrC(IV) is targeting the O-
antigen capsule as it is structurally very similar and contains a galactose sugar. To test whether 
this is the case the O-antigen capsule of a cell constitutively expressing the family IV genes 
needs to be analysed. The O-antigen capsule can be separated from the LPS based on their 
charge. Once fatty acids are removed from the O-antigen capsule it has a low charge whereas 
the LPS O-antigen is small with a high charge. O-antigen capsule analysis is more difficult than 
LPS analysis as the capsules repeating units can be as many as 2,300 or more. Therefore, when 
analysed using gel electrophoresis the O-antigen capsule can not separate out into a banding 
pattern and will migrate into a thick band at the separating and stacking gel interface (Snyder et 
al., 2006). But the composition of the O-antigen capsule can be determined by NMR 
spectroscopy.  
 
Studies of the expression of the family IV genes demonstrated that gtrC(IV) could be expressed 
independently of the main operon. This could mean that it can function independently of 
GtrAB(IV) as results in section 4.1.2. showed that the two promoters might have different 
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transcriptional controls. This could be a sign that expression of GtrC(IV) from the main operon 
promoter does not fit the needs of its function and has adapted to function slightly differently 
from the original operons function. For example, it may be functioning at a different location 
within the membrane and with other glucosyl transferase proteins. This could support the theory 
that GtrC(IV) is not targeting the O-antigen and has adapted to target another membrane 
polysaccharide with different expression needs like the O-antigen capsule for example, unlike 
the LPS the O-antigen capsule is not always present on the cell surface (Marshall and Gunn, 
2015).  
 
This theory suggests that GtrAB(IV) is no longer working with GtrC(IV) due the possible 
difference in their expression controls. As GtrAB(IV) appears to still be functional, as 
demonstrated in chapter 6, it may be the case that GtrAB(IV) is working with other GtrC 
proteins in the cell, which was also shown to be possible in chapter 6.    
 
On the other hand, if the O-antigen is the target of GtrC(IV) and a further modification is 
needed then presumably both the S. Typhimurium and S. Infantis don’t have the target present 
in their basal O-antigen. Strains from both serovars have shown no detectable modification of 
the basal O-antigen when gtrABC(IV) were constitutively expressed (Davies et al., 2013).  The 
S. Typhimurium core O-antigen contains a galactose sugar but the sugar has been reported to 
have both beta and alpha anomeric forms. As anomeric configuration can be a determinant of 
specificity for some O-antigen modifying proteins, this could be the reason why no 
modification was seen in the S. Typhimurium serovar. S. Infantis is part of the O:7 group 
serovars so does not contain a galactose, a possible target of GtrC(IV). Although chapter 5 did 
not show that either the modifications mediated by the family V or VI proteins provided 
GtrC(IV) with a target there is still the possibility that other genes on the S. Infantis genome 
mediate the addition of a galactose, if this is the target of GtrC(IV). Or, the family V or VI 
proteins transfer a galactose onto the O-antigen but this is also in the wrong anomeric 
configuration and is able to be changed.  
 
If the O-antigen is the target of GtrC(IV) it maybe the case that not all of the O-antigen core 
structures of the family IV serovars need a modification to the O-antigen to provide GtrC(IV) 
with a target. Hence, other experiments could look at the effect of gtrABC(IV) constitutive 
expression on the O-antigen of other serovars that naturally contain the family IV genes that 
aren’t part of O-antigen groups that have already been studied. The O:8 group seems the most 
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promising group to study as there are three serovars containing the family IV genes that belong 
to the O:8 group, whereas the other un-studied groups only contain one family IV serovar.  
 
7.5 CONCLUDING REMARKS 
 
From the results of this project it seems more likely that the target of the family IV Gtr proteins 
may not be the O-antigen. There is no common sugar between the identified core O-antigen 
structures and GtrABC(IV) has not been shown to modify the O-antigen after modifications 
mediated by other Gtr proteins. Also supporting this conclusion is the possibility of GtrC(IV) 
being independently expressed and having different transcriptional controls from the main 
promoter suggesting that its function is distinct from other studied Gtr proteins and needs to be 
expressed at different times and may function alone. The O-antigen capsule is a good candidate 
for the possible target of GtrC(IV) because its structure is very similar to the O-antigen.  
However, there is still the possibility that the basal O-antigen of S. Typhimurium and S. Infantis 
needs to be modified in some way to provide a target for GtrC(IV) activity. As the serovars 
containing the family IV genes have diverse core O-antigen structures future experiments could 
look at the effect of constitutive expression of the family IV genes in other serovars that 
naturally contain the family IV genes.  
Structures on the surface of bacteria can play crucial roles in infection, as the family IV proteins 
are thought to modify the surface of the Salmonella pathogen knowledge of their function could 
give us a deeper understanding of salmonellosis. Furthermore, this body of work has given an 
insight into the function of the family IV proteins and provided a basis for future studies.  
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APPENDICES 
APPENDIX 1 – TABLES OF BUFFERS, GELS AND MEDIA  
Table A1.1: PCN media 
Component		 Final	concentration	
MES	 0.08	M	
Tricine	 4	mM	
NaCl	 0.05	M	
D-Glucose	 0.022	M	
NH4Cl	 0.015	M	
MgSO4	 1	mM	
CaCl2	 0.01	μM	
Na2MoO4	 0.01	μM	
Na2SeO3	 0.3	μM	
CoCl2	 0.1	μM	
CuSO4	 0.8	μM	
MnCl2	 0.001	μM	
ZnSO4	 0.004	μM	
H3BO3	 0.1	mM	
FeCl3	 0.376	mM	
K2SO4	 0.4	mM	
K2HPO4/KH2PO4*	 0.4	mM	
*	K2HPO4	and	KH2PO4	were	combined	at	a	ratio	of	1:10.76		
 
Table A1.2: M9 minimal media 
Component	 Final	Concentration	
M9	Minimal	Salts	
	Fe	Citrate	 0.002	mM	
CaCl2	 0.1	mM	
MgSO4	 1	mM	
Vitamin	B1		 0.03	mM	
Glucose	 10	mM	
Xgal*	 0.1	mM	
*was	dissolved	in	DMF.	Only	added	when	making	solid	media		
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Table A1.3: SOC media 
Component	 Final	Concentration	
Tryptone	 2%	(W/V)	
Yeast	Extract	 0.5%	(W/V)	
NaCL	 10	mM	
KCL	 2.5	mM	
MgCl2	 10	mM	
MgSO4	 10	mM	
Glucose	 20	mM		
Filter	Sterilized	after	dissolving		
 
Table A1.4: LPS buffer A/B 
Component	 Final	Concentration	
Tris-HCl	 60	mM	
EDTA	 1	mM	
SDS*	 2%	(W/V)	
pH	6.8	
*Only	in	LPS	Buffer	A	
 
Table A1.5: Separating gel  
Component	 Final	Concentration	
Gel	buffer	(Table	X)	 33.2%	(V/V)	
Acrylamide		 10%	(V/V)	
Glycerol		 10.4%	(V/V)	
APS*	 0.06%	(W/V)	
TEMED*	 0.6	μl/ml	
*	were	added	just	before	casting	
 
Table A1.6: Stacking gel 
Component	 Final	Concentration	
Gel	buffer	(Table	X)	 24.8%	(V/V)	
Acrylamide		 4%	(V/V)	
APS*	 0.08%	(W/V)	
TEMED*	 0.8	μl/ml	
*	were	added	just	before	casting	
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Table A1.7: Cathode buffer 
Component	 Final	Concentration	
Tris	 0.1	M	
Tricine	 0.1	M	
SDS	 0.1%	(W/V)	
 
Table A1.8: Fixative solution 
Component	
Final	
Concentration	
Ethanol	 30%	(V/V)	
Acetic	Acid		 10%	(V/V)	
 
Table A1.9:  Oxidizer solution 
Component	
Final	
Concentration	
Periodic	acid	 0.033	M	
Ethanol	 30%	(V/V)	
Acetic	Acid		 10%	(V/V)	
 
Table A1.10: Developer solution 
Component	
Final	
Concentration	
Sodium	Carbonate	 0.28	M	
Formaldehyde	 0.0074%	(V/V)	
 
Table A1.11: Loading buffer 
Component	
Final	
Concentration	
SDS	 6%	(W/V)	
2-mercaptoethanol	 6%	(V/V)	
Dithiothreitol	 10	mM	
Glycerol	 46%	(V/V)	
Tris	(pH8)	 60	mM	
Bromophenol	blue	 0.1%	(W/V)	
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Table A1.12: Gel buffer 
Component	 Final	Concentration	
Tris	 3	M	
SDS	 0.3%	(W/V)	
pH	to	8.45	
 
 
Table A1.13 Z buffer 
Component	 Final	Concentration	
Anhydrous Na2HPO4 0.06 M 
Anhydrous NaH2PO4  0.04 M 
KCl  0.01 M 
MgSO4 0.001 M 
b-Mercaptoethanol  0.05 M 
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APPENDIX 2 – TABLES OF OLIGOS, PRIMERS AND 
STRAINS 
 
Table A2.1: Oligos 
  
Code Sequence Direction Purpose
oMV1216 GATTGTTTCGCCGCTTCCTC R RT-qPCR	primer.	Aplify	a	
region	within	modF,	
refrence	gene	for	pH3	
shock	
oMV1217 CTAAATCGCGTCAGGCAACG F RT-qPCR	primer.	Aplify	a	
region	within	yibT,	refrence	
gene	for	pH3	shock	
oMV1218 GCTCAAAACGGATGAACGGG R RT-qPCR	primer.	Aplify	a	
region	within	yibT,	refrence	
gene	for	pH3	shock	
oMV1246 GATGTGGCATGAGGAAACGG F RT-qPCR	primer.	Aplify	a	
region	within	STM1575,	
refrence	gene	for	NO	shock	
oMV1247 GCACACCAGTGCGATAAGC R RT-qPCR	primer.	Aplify	a	
region	within	STM1575,	
refrence	gene	for	NO	shock	
oMV1248 GCTTCAGTGCTGGTAATCGTG F RT-qPCR	primer.	Aplify	a	
region	within	kdgR,	
refrence	gene	for	NO	shock	
oMV1249 GCCATCGGTAAAGTGCTTCTG R RT-qPCR	primer.	Aplify	a	
region	within	kdgR,	
refrence	gene	for	NO	shock	
oMV1254 TACTACGGTACCCGTCAACCACC
ATCAAACAGG
F Forward	primer	to	amplify	
the	whole	of	the	Plac22	
plasmid	excuding	the	lacIq	
gene.	Is	positioned	at	the	
end	of	the	lacIq 	coding	
region
oMV1255 TGATTTGGGTACCTGCCATACCG
CGAAAGGTT
R Reverse	primer	to	amplify	
the	whole	of	the	Plac22	
plasmid	excuding	the	lacIq	
gene.	Is	positioned	
upstream	of	the	lacIq	 start	
codon.
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Table A2.1: Oligos (continued) 
    
Code Sequence Direction Purpose
oMV1065 GGTAGCTCTGCAGTTCAGCGCA
ACGTGATTAGT
F Aplify	the	355pb	up	stream	
and	overlapping	region	of	
gtrA(IV)	to	clone	into	the	
CRIM	vector	infront	of	the	
lacZ	gene.	Contains	the	Pst1	
restriction	site
oMV1166 CATGATGGTACCAAACTGACA
GCGACAGAAA
R Aplify	the	355pb	up	stream	
and	overlapping	region	of	
gtrA(IV)	to	clone	into	the	
CRIM	vector	infront	of	the	
lacZ	gene.	Contains	the	
Acc651	restriction	site
oMV1184 CATGATGGTACCAGTAGTATCATCGCCGTTTTCGR Aplify	a	581bp	region	within	
gtrB(IV)	containing	possible	
TSS	for	gtrC(IV)	to	clone	into	
the	CRIM	vector	infront	of	
the	lacZ	gene.	Contains	the	
Acc651	restriction	site
oMV1186 GGTAGCTCTGCAGAAGCGCTG
AGTGGTTCTACAG
F Aplify	a	581bp	region	within	
gtrB(IV)	containing	possible	
TSS	for	gtrC(IV)	to	clone	into	
the	CRIM	vector	infront	of	
the	lacZ	gene.	Contains	the	
Pst1	restriction	site
oMV1209 GTTTACCTTTGGAGCCAGCG F RT-qPCR	primer.	Aplify	a	
region	within	gtrA(IV)
oMV1210 CATAGCACACTTGTCGCCTG R RT-qPCR	primer.	Aplify	a	
region	within	gtrA(IV)
oMV1213 TGTTCGTTGTTGCATGGCTG F RT-qPCR	primer.	Aplify	a	
region	within	gtrC(IV)
oMV1214 GAGACGAAAGGTGAGACGCT R RT-qPCR	primer.	Aplify	a	
region	within	gtrC(IV)
oMV1215 CAGATCGTCGGTCCTAACGG F RT-qPCR	primer.	Aplify	a	
region	within	modF,	refrence	
gene	for	pH3	shock	
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Table A2.2: Plasmids 
   
Name	 Code	 Descriotion Anitbiotic	
Resistance	
Primers	used	
to	modify	
Source	
CRIM	vector	 p243 Contains	the	lacZ	
gene,	an	attp	site	for	
site	specific	
intogration,	
replication	origin	of	
R6K	(needs	pir+	
strain)	
Chloramphen
icol	
-
Plac22 - Vector	containing	
the	lac	promoter	and	
lacIq	repressor	gene
Ampacilin,	
Tetracyclin
-
reg	gtrA(IV)-
lacZ
p440 CRIM	vector	with	a	
355bp	region	taken	
from	upstream	and	
overlapping	gtrA(IV)	
cloned	upstream	of	
lacZ	
Chloramphen
icol
oMV1065,	
oMV1166
van	der	
Woude	
Stocks	
(modified-
this	project)
within	
gtrB(IV)-lacZ
p442 CRIM	vector	with	a	
581bp	region	taken	
from	within	gtrB(IV)	
cloned	upstream	of	
lacZ	
Chloramphen
icol
oMV1184,	
oMV1186
van	der	
Woude	
Stocks	
(modified-
this	project)
lac-
grtABC(IV)
p447 LT2	gtrABC(IV)	
cloned	into	Plac22	
downstream	of	the	
lac	promotor.	
Ampacilin,	
Tetracyclin
van	der	
Woude	
Stocks
plac22-lacIq p459 Plac22	plasmid	with	
the	lacIq	repressor	
gene	cut	out	using		
oMV	1254,	
oMV1255
Ampacilin,	
Tetracyclin
	oMV	1254,	
oMV1255
van	der	
Woude	
Stocks	
(modified-
this	project)
lac-gtrABC(I) p460 p459	with	gtrABC(I)	
under	the	lac	
promoter
Ampacilin,	
Tetracyclin
	oMV	1254,	
oMV1255
van	der	
Woude	
Stocks	
(modified-
this	project)
lac-gtrC(I) p461 p459	with	gtrC(I)	
under	the	lac	
promoter
Ampacilin,	
Tetracyclin
	oMV	1254,	
oMV1255
van	der	
Woude	
Stocks	
(modified-
this	project)
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Table A2.3: Strains 
 
   
Name	 Code	 Descriotion Anitbiotic	
Resistance	
Primers	
used	to	
modify	
Source	
CRIM	vector	 p243 Contains	the	 lacZ	
gene,	an	attp	site	
for	site	specific	
intogration,	
replication	origin	
of	R6K	(needs	pir+	
strain)	
Chloramphe
nicol	
-
Plac22 - Vector	containing	
the	lac	promoter	
and	lacIq	repressor	
gene
Ampicillin,	
Tetracyclin	
-
reg	gtrA(IV)-
lacZ
p440 CRIM	vector	with	a	
355bp	region	taken	
from	upstream	and	
overlapping	
gtrA(IV)	cloned	
upstream	of	lacZ	
Chloramphe
nicol
oMV1065,	
oMV1166
van	der	
Woude	
Stocks	
(modified-
this	project)
within	
gtrB(IV)-lacZ
p442 CRIM	vector	with	a	
581bp	region	taken	
from	within	
gtrB(IV)	cloned	
upstream	of	lacZ	
Chloramphe
nicol
oMV1184,	
oMV1186
van	der	
Woude	
Stocks	
(modified-
this	project)
lac-
grtABC(IV)
p447 LT2	gtrABC(IV)	
cloned	into	Plac22	
downstream	of	the	
lac	promotor.	
Ampicillin,	
Tetracyclin
van	der	
Woude	
Stocks
plac22-lacIq p459 Plac22	plasmid	
with	the	lacIq	
repressor	gene	cut	
out	using		oMV	
1254,	oMV1255
Ampicillin,	
Tetracyclin
	oMV	1254,	
oMV1255
van	der	
Woude	
Stocks	
(modified-
this	project)
lac-
gtrABC(I)
p460 p459	with	
gtrABC(I)	under	the	
lac	promoter
Ampicillin,	
Tetracyclin
	oMV	1254,	
oMV1255
van	der	
Woude	
Stocks	
(modified-
this	project)
lac-gtrC(I) p461 p459	with	gtrC(I)	
under	the	lac	
promoter
Ampicillin,	
Tetracyclin
	oMV	1254,	
oMV1255
van	der	
Woude	
Stocks	
(modified-
this	project)
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Table A2.3: Strains (continued)  
 
   
Name	 Srain	code	 Genotype Plasmid source
SIN	Ptac-
gtrABC(VI)
Strain	321 Salmonella	Infantis	S1326/2,	delta:gtrABC(IV)::kan	
resistant,	delta::gtrABC(V),	delta:reg-
gtrABC(Vi)::Ptac
- van	der	Woude	
Stocks
SIN	Ptac-
gtrABC(VI)/pla
c22
Strain	929 Salmonella	Infantis	S1326/2,	delta:gtrABC(IV)::kan	
resistant,	delta::gtrABC(V),	delta:reg-
gtrABC(Vi)::Ptac
Plac22 van	der	Woude	
Stocks
SIN	Ptac-
gtrABC(VI)/p4
47
Strain	930	 Salmonella	Infantis	S1326/2,	delta:gtrABC(IV)::kan	
resistant,	delta::gtrABC(V),	delta:reg-
gtrABC(Vi)::Ptac
p447 van	der	Woude	
Stocks
STM	Ptac-
gtrABC(III)
Strain	122 Salmonella	Typhimurium	LT2,	delta:oafA,	
delta:gtrABC(IV)::kan	resistant,	delta:reg-
gtrABC(III)::Ptac
- van	der	Woude	
Stocks
STM	Ptac-
gtrABC(III)/gtr
ABC(IV)
Strain	921 Salmonella	Typhimurium	LT2,	delta:oafA,	
delta:gtrABC(IV)::kan	resistant,	delta:reg-
gtrABC(III)::Ptac
p447 van	der	Woude	
Stocks
Basal	
STM/gtrABC(I)
Strain	967 Basal	Salmonella	Typhimurium	LT2,	delta:oafA,	
delta:gtrABC(III)::tet	resistant,	
delta:gtrABC(IV)::Kan	resistant	
p460 van	der	Woude	
Stocks	
(transformation	-	
this	project)
Basal	
STM/plac22
Strain	966 Basal	Salmonella	Typhimurium	LT2,	delta:oafA,	
delta:gtrABC(III)::tet	resistant,	
delta:gtrABC(IV)::Kan	resistant	
p459 van	der	Woude	
Stocks	
(transformation	-	
this	project)
Basal	
STM/gtrC(I)
Strain	968 Basal	Salmonella	Typhimurium	LT2,	delta:oafA,	
delta:gtrABC(III)::tet	resistant,	
delta:gtrABC(IV)::Kan	resistant	
p461 van	der	Woude	
Stocks	
(transformation	-	
this	project)
STM	Ptac-
gtrAB(IV)/gtrC(
I)
Strain	970 Basal	Salmonella	Typhimurium	LT2,	delta:oafA,	
delta:gtrABC(III)::kan	resistant,	delta:reg-
gtrABC(IV)::Ptac	delta:gtrC(IV)::tet	resistant
p461 van	der	Woude	
Stocks	
(transformation	-	
this	project)
STM	Ptac-
gtrAB(IV)/Plac
22
Strain	969 Basal	Salmonella	Typhimurium	LT2,	delta:oafA,	
delta:gtrABC(III)::kan	resistant,	delta:reg-
gtrABC(IV)::Ptac	delta:gtrC(IV)::tet	resistant
p459 van	der	Woude	
Stocks	
(transformation	-	
this	project)
Basal	
STM/Ptac-
gtrAB(IV)
Strain	141 Basal	Salmonella	Typhimurium	LT2,	delta:oafA,	
delta:gtrABC(III)::kan	resistant,	delta:reg-
gtrABC(IV)::Ptac	delta:gtrC(IV)::tet	resistant
- van	der	Woude	
Stocks
STM	LT2 Strain	917 Salmonella	Typhimurium	LT2.	p440	intograted	
into	the	lambda	att	site
- This	Project
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APPENDIX 3 – BIOINFORMATICS FIGURES 
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Figure A3.1: GtrC, from 6 different Gtr families, AA alignment. 
After each sequence is the name of the serovar, strain and gtr family the sequence belongs to. Numbers 
either side of the sequences are the first and last AA number. Bracketed numbers in grey are AA that 
are not shown and indicates how many. Lower case AA in grey show low-complexity sequences that 
have been filtered out when building the alignment.  Coloured regions indicate the sequences have 
some conservation; red indicates AA conserved across all of the proteins and blue shows that some 
proteins have a change in AAs. The blue lines underneath the sequences indicate the transmembrane 
regions of the family IV GtrB protein. 
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